AvePoint (AVPT) S-4/A 28 May 21 Registration of securities issued in business combination transactions (amended) Financial data

Cover

Cover	3 Months Ended
	Mar. 31, 2021
Cover [Abstract]
Document Type	S-4/A
Amendment Flag	false
Entity Registrant Name	Apex Technology Acquisition Corp
Entity Central Index Key	0001777921
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Current Assets
Cash	$ 139,492	$ 197,628	$ 994,810
Prepaid expenses and other current assets	105,083	74,642	183,639
Prepaid income taxes	477,437	477,437
Total Current Assets	722,012	749,707	1,178,449
Cash and marketable securities held in Trust Account	351,890,161	351,858,320	351,809,163
Total Assets	352,612,173	352,608,027	352,987,612
Current liabilities
Accounts payable and accrued expenses	6,004,128	4,408,489	5,000
Franchise tax payable	50,000	81,255	148,543
Income taxes payable			464,701
Convertible promissory note - related party	300,000
Total Current Liabilities	6,354,128	4,489,744	618,244
Deferred underwriting commissions	13,150,000	13,150,000	13,150,000
Warrant liabilities	47,247,250	77,419,100	20,947,150
TOTAL LIABILITIES	66,751,378	95,058,844	34,715,394
Commitments and Contingencies
Class A common stock subject to possible redemption, 25,254,918 and 31,327,221 shares as of December 31, 2020 and 2019 (at $10.00 per share), respectively	280,860,790	252,549,180	313,272,210
Stockholders' Equity
Preferred stock, $0.0001 par value; 1,000,000 shares authorized, none issued and outstanding
Additional paid-incapital	34,444,413	62,755,739	2,033,317
(Accumulated deficit) Retained earnings	(29,446,055)	(57,757,667)	2,965,368
Total Stockholders' Equity	5,000,005	5,000,003	5,000,008
Total Liabilities and Stockholders' Equity	352,612,173	352,608,027	352,987,612
Class A Common Stock
Stockholders' Equity
Common stock, value	772	1,056	448
Total Stockholders' Equity	772	1,056	448
Class B Common Stock
Stockholders' Equity
Common stock, value	875	875	875
Total Stockholders' Equity	$ 875	$ 875	$ 875

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Mar. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Preferred shares, par value	$ 0.0001	$ 0.0001	$ 0.0001
Preferred shares, shares authorized	1,000,000	1,000,000	1,000,000
Preferred shares, shares issued	0	0	0
Preferred shares, shares outstanding	0	0	0
Class A Common Stock
Common stock subject to possible redemption, par value (in Dollars per share)	$ 0.0001
Common stock subject to possible redemption	28,086,079	25,254,918	31,327,221
Common stock subject to possible redemption per share	$ 10	$ 10	$ 10
Common stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares authorized	100,000,000	100,000,000	100,000,000
Common stock, shares issued	7,723,921	10,555,082	4,482,779
Common stock, shares outstanding	7,723,921	10,555,082	4,482,779
Class B Common Stock
Common stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares authorized	10,000,000	10,000,000	10,000,000
Common stock, shares issued	8,750,000	8,750,000	8,750,000
Common stock, shares outstanding	8,750,000	8,750,000	8,750,000

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended	12 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2019	Dec. 31, 2020
Income Statement [Abstract]
General and administrative expenses	$ 1,842,079	$ 194,283	$ 295,109	$ 5,309,612
Franchise tax expense	50,000	50,000	295,342	201,196
Loss from operations	(1,892,079)	(244,283)	(590,451)	(5,510,808)
Other income (expense):
Change in fair value of warrant liabilities	30,171,850	4,294,000	3,052,800	(56,471,950)
Interest earned on marketable securities held in Trust Account	31,841	1,452,414	1,809,163	1,671,038
Transaction costs - warrants			(988,242)
Other income (expense), net	30,203,691	5,746,414	3,873,721	(54,800,912)
(Loss) income before provision for income taxes	28,311,612	5,502,131	3,283,270	(60,311,720)
Provision for income taxes		(392,446)	(317,902)	(411,315)
Net (loss) income	$ 28,311,612	$ 5,109,685	$ 2,965,368	$ (60,723,035)
Weighted average shares outstanding of Class A redeemable common stock	35,000,000	35,000,000	35,000,000	35,000,000
Basic and diluted income per share, Class A redeemable common stock	$ 0	$ 0.03	$ 0.03	$ 0.03
Basic weighted average shares outstanding of Class A and Class B non-redeemablecommon stock	9,560,000	9,560,000	9,062,000	9,560,000
Basic and diluted net loss per share, Class A and Class B non-redeemablecommon stock	$ 2.96	$ 0.43	$ 0.20	$ (6.46)
Diluted weighted average shares outstanding of Class A and Class B non-redeemablecommon stock	12,757,321	9,560,000
Diluted net income per share, Class A and Class B non-redeemable common stock	$ (0.15)	$ (0.02)

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY - USD ($)	Total	Additional Paid-in Capital	Retained Earnings	Class A Common Stock	Class B Common Stock
Beginning Balance at Apr. 04, 2019	$ 0	$ 0	$ 0	$ 0	$ 0
Beginning Balance, shares at Apr. 04, 2019				0
Issuance of Class B common stock to Sponsor	25,000	24,123			$ 877
Issuance of Class B common stock to Sponsor					8,786,750
Forfeiture of Class B common stock		2			$ (2)
Forfeiture of Class B common stock, shares					(18,750)
Sale of 35,000,000 Units, net of underwriting discount and offering costs and the fair value of the Public Warrants	307,906,800	307,903,300		$ 3,500
Sale of 35,000,000 Units, net of underwriting discount and offering costs and the fair value of the Public Warrants, shares				35,000,000
Sale of 810,000 Private Placement Units, net of the fair value of the Private Placement Warrants	7,375,050	7,374,969		$ 81
Sale of 810,000 Private Placement Units, net of the fair value of the Private Placement Warrants, shares				810,000
Common stock subject to possible redemption	(313,272,210)	(313,269,077)		$ (3,133)
Common stock subject to possible redemption, shares				(31,327,221)
Net income (loss)	2,965,368		2,965,368
Ending Balance at Dec. 31, 2019	5,000,008	2,033,317	2,965,368	$ 448	$ 875
Ending Balance, shares at Dec. 31, 2019				4,482,779	8,750,000
Issuance of Class B common stock to Sponsor	(5,109,690)	(2,033,317)	(3,076,322)	$ (51)
Issuance of Class B common stock to Sponsor				510,969
Net income (loss)	5,109,685		5,109,685
Ending Balance at Mar. 31, 2020	5,000,004		4,998,731	$ 397	$ 875
Ending Balance, shares at Mar. 31, 2020				3,971,810	8,750,000
Beginning Balance at Dec. 31, 2019	5,000,008	2,033,317	2,965,368	$ 448	$ 875
Change in value of Class A common stock subject to possible redemption	60,723,030	60,722,422		$ 608
Beginning Balance, shares at Dec. 31, 2019				4,482,779	8,750,000
Change in value of Class A common stock subject to possible redemption, shares				6,072,303
Net income (loss)	(60,723,035)		(60,723,035)
Ending Balance at Dec. 31, 2020	5,000,003	62,755,739	(57,757,667)	$ 1,056	$ 875
Ending Balance, shares at Dec. 31, 2020				10,555,082	8,750,000
Common stock subject to possible redemption	(28,311,610)	(28,311,326)		$ (284)
Common stock subject to possible redemption, shares				(2,831,161)
Net income (loss)	28,311,612		28,311,612
Ending Balance at Mar. 31, 2021	$ 5,000,005	$ 34,444,413	$ (29,446,055)	$ 772	$ 875
Ending Balance, shares at Mar. 31, 2021				7,723,921	8,750,000

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY (Parenthetical)	9 Months Ended
	Dec. 31, 2019shares
Initial Public Offering [Member]
Net of underwriting discount and offering costs and the fair value of the public warrants	35,000,000
Private Placement Warrants [Member]
Sale of private placement units	810,000

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended		9 Months Ended	12 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2019	Dec. 31, 2020
Cash Flows from Operating Activities:
Net (loss) income	$ 28,311,612	$ 5,109,685	$ 2,965,368	$ (60,723,035)
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account	(31,841)	(1,452,414)	(1,809,163)	(1,671,038)
Change in fair value of warrant liabilities	(30,171,850)	(4,294,000)	(3,052,800)	56,471,950
Transaction costs			988,242
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	(30,441)	(41,061)	(183,639)	108,997
Prepaid income taxes				(477,437)
Accounts payable and accrued expenses	1,595,639	(145,620)	151,799	4,256,690
Franchise tax payable	(31,255)	(98,743)	148,543	(67,288)
Income taxes payable		539,245	317,902	(317,902)
Net cash used in operating activities	(358,136)	(382,908)	(473,748)	(2,419,063)
Cash Flows from Investing Activities:
Investment of cash into Trust Account			(350,000,000)
Cash withdrawn from Trust Account for franchise and income taxes		148,743		1,621,881
Net cash provided by (used in) investing activities		148,743	(350,000,000)	1,621,881
Cash Flows from Financing Activities
Proceeds from issuance of Class B common stock to Sponsor			25,000
Proceeds from sale of Units, net of underwriting discounts paid			343,900,000
Proceeds from sale of Private Units			8,100,000
Proceeds from convertible promissory note - related party	300,000		275,000
Repayment of promissory note - related party			(275,000)
Payment of offering costs			(556,442)
Net cash provided by financing activities	300,000		351,468,558
Net Change in Cash	(58,136)	(234,165)	994,810	(797,182)
Cash - Beginning of period	197,628	994,810		994,810
Cash - End of period	139,492	760,645	994,810	197,628
Non-cash investing and financing activities:
Initial classification of Class A common stock subject to possible redemption			309,314,540
Change in value of Class A common stock subject to possible redemption	$ 28,311,610	$ 5,109,690	3,957,670	$ (60,723,030)
Deferred underwriting fee payable			$ 13,150,000

DESCRIPTION OF ORGANIZATION AND

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Apex Technology Acquisition Corporation (the “Company”) was incorporated in Delaware on April 5, 2019. The Company was formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). Although the Company is not limited to a particular industry or sector for purposes of consummating a Business Combination, the Company intends to focus its search on companies in the software and internet technology industries. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. The Company has two subsidiaries, Athena Technology Merger Sub, Inc., a wholly-owned subsidiary of the Company incorporated in Delaware on October 13, 2020 (“Merger Sub 1”) and Athena Technology Merger Sub 2, LLC, a wholly-owned subsidiary of the Company incorporated in Delaware on November 2, 2020 (“Merger Sub 2”). As of March 31, 2021, the Company had not commenced any operations. All activity through March 31, 2021 relates to the Company’s formation, its initial public offering (the “Initial Public Offering”), which is described below identifying a target company for a Business Combination and activities in connection with the proposed acquisition of AvePoint, Inc., a Delaware corporation (“AvePoint”) (see Note 6). The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating The registration statement for the Company’s Initial Public Offering was declared effective on September 16, 2019. On September 19, 2019, the Company consummated the Initial Public Offering of 35,000,000 units (“Units” and, with respect to the Class A common stock included in the Units offered, the “Public Shares”), which included the partial exercise by the underwriters of the over-allotment option to purchase an additional 4,500,000 Units, at $10.00 per Unit, generating gross proceeds of $350,000,000, which is described in Note 3. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 810,000 units (the “Placement Units”) at a price of $10.00 per Placement Unit in a private placement to Apex Technology Sponsor LLC, a Delaware limited liability company (the “Sponsor”) and Cantor Fitzgerald & Co. (“Cantor”), the representative of the underwriters, generating gross proceeds of $8,100,000, which is described in Note 4. Offering costs amounted to $19,806,442, consisting of $6,100,000 of underwriting fees, $13,150,000 of deferred underwriting fees and $556,442 of other offering costs. Following the closing of the Initial Public Offering on September 19, 2019, an amount of $350,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Placement Units was placed in a trust account (“Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on interest earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide its holders of the outstanding shares of Class A common stock (the “public stockholders”) included in the public units (“Public Shares”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account ($10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share If the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company. The Sponsor has agreed (a) to waive its redemption rights with respect to its Founder Shares (as defined below), Placement Shares (as defined below) and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Certificate of Incorporation (i) that would affect the substance or timing of the Company’s obligation to allow redemption in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination or (ii) with respect to any other provision relating to stockholders’ rights or pre-business The Company has until September 19, 2021 to consummate a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares and Placement Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than $10.00 per share. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Going Concern In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15,	NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Apex Technology Acquisition Corporation (the “Company”) was incorporated in Delaware on April 5, 2019. The Company was formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). Although the Company is not limited to a particular industry or sector for purposes of consummating a Business Combination, the Company intends to focus its search on companies in the software and internet technology industries. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. The Company has two subsidiaries, Athena Technology Merger Sub, Inc., a wholly-owned subsidiary of the Company incorporated in Delaware on October 13, 2020 (“Merger Sub 1”) and Athena Technology Merger Sub 2, LLC, a wholly -owned subsidiary of the Company incorporated in Delaware on November 2, 2020 (“Merger Sub 2”). As of December 31, 2020, the Company had not commenced any operations. All activity through December 31, 2020 relates to the Company’s formation, its initial public offering (the “Initial Public Offering”), which is described below, identifying a target company for a Business Combination and activities in connection with the proposed acquisition of AvePoint, Inc., a Delaware corporation (“AvePoint”) (see Note 7). The Company will not generate any operating revenue until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating The registration statement for the Company’s Initial Public Offering was declared effective on September 16, 2019. On September 19, 2019, the Company consummated the Initial Public Offering of 35,000,000 units (“Units” and, with respect to the Class A common stock included in the Units offered, the “Public Shares”), which included the partial exercise by the underwriters of the over-allotment option to purchase an additional 4,500,000 Units, at $10.00 per Unit, generating gross proceeds of $350,000,000, which is described in Note 4. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 810,000 units (the “Placement Units”) at a price of $10.00 per Placement Unit in a private placement to Apex Technology Sponsor LLC, a Delaware limited liability company (the “Sponsor”) and Cantor Fitzgerald & Co. (“Cantor”), the representative of the underwriters, generating gross proceeds of $8,100,000, which is described in Note 5. Offering costs amounted to $19,806,442, consisting of $6,100,000 of underwriting fees, $13,150,000 of deferred underwriting fees and $556,442 of other offering costs. Following the closing of the Initial Public Offering on September 19, 2019, an amount of $350,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Placement Units was placed in a trust account (“Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on interest earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide its holders of the outstanding shares of Class A common stock (the “public stockholders”) included in the public units (“Public Shares”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account ($10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share If the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company. The Sponsor has agreed (a) to waive its redemption rights with respect to its Founder Shares (as defined below), Placement Shares (as defined below) and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Certificate of Incorporation (i) that would affect the substance or timing of the Company’s obligation to allow redemption in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination or (ii) with respect to any other provision relating to stockholders’ rights or pre-business The Company has until September 19, 2021 to consummate a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares and Placement Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 7) held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than $10.00 per share. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Going Concern In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15,

RESTATEMENT OF PREVIOUSLY ISSUE

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	12 Months Ended
	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	NOTE 2. RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS The Company previously accounted for its outstanding Public Warrants (as defined in Note 5) and Private Placement Warrants issued in connection with its Initial Public Offering as components of equity instead of as derivative liabilities. The warrant agreement governing the warrants includes a provision that provides for potential changes to the settlement amounts dependent upon the characteristics of the holder of the warrant. In addition, the warrant agreement includes a provision that in the event of a tender or exchange offer made to and accepted by holders of more than 50% of the outstanding shares of a single class of common shares, all holders of the warrants would be entitled to receive cash for their warrants (the “tender offer provision”). In connection with the audit of the Company’s financial statements for the period ended December 31, 2020, the Company’s management further evaluated the warrants under Accounting Standards Codification (“ASC”) Subtopic 815-40, Section 815-40-15 Section 815-40-15, Section 815-40-15 fixed-for-fixed Section 815-40-25. As a result of the above, the Company should have classified the warrants as derivative liabilities in its previously issued financial statements. Under this accounting treatment, the Company is required to measure the fair value of the warrants at the end of each reporting period and recognize changes in the fair value from the prior period in the Company’s operating results for the current period. The Company’s accounting for the warrants as components of equity instead of as derivative liabilities did not have any effect on the Company’s previously reported operating expenses, cash flows or cash. As Previously Adjustments As Restated Balance sheet as of September 19, 2019 (audited) Total Liabilities $ 13,150,815 $ 23,999,950 $ 37,150,765 Class A Common Stock Subject to Possible Redemption 333,314,490 (23,999,950 ) 309,314,540 Class A Common Stock 248 240 488 Additional Paid-in 5,002,945 988,003 5,990,948 Accumulated Deficit (4,065 ) (988,243 ) (992,308 ) Total Stockholders’ Equity 5,000,003 — 5,000,003 Number of Class A common stock subject to redemption 33,331,449 (2,399,995 ) 30,931,454 Balance sheet as of September 30, 2019 (unaudited) Total Liabilities $ 13,284,099 $ 23,829,000 $ 37,113,099 Class A Common Stock Subject to Possible Redemption 333,347,150 (23,829,000 ) 309,518,150 Class A Common Stock 248 238 486 Additional Paid-in 4,970,285 817,055 5,787,340 (Accumulated Deficit) Retained Earnings 28,595 (817,293 ) (788,698 ) Total Stockholders’ Equity 5,000,003 — 5,000,003 Number of Class A common stock subject to redemption 33,334,715 (2,382,900 ) 30,951,815 Balance sheet as of December 31, 2019 (audited) Total Liabilities $ 13,768,244 $ 20,947,150 $ 34,715,394 Class A Common Stock Subject to Possible Redemption 334,219,360 (20,947,150 ) 313,272,210 Class A Common Stock 239 209 448 Additional Paid-in 4,098,084 (2,064,767 ) 2,033,317 Retained Earnings 900,810 2,064,558 2,965,368 Total Stockholders’ Equity 5,000,008 — 5,000,008 Number of Class A common stock subject to redemption 33,421,936 (2,094,715 ) 31,327,221 Balance sheet as of March 31, 2020 (unaudited) Total Liabilities $ 14,063,126 $ 16,653,150 $ 30,716,276 Class A Common Stock Subject to Possible Redemption 335,035,050 (16,653,150 ) 318,381,900 Class A Common Stock 231 166 397 Additional Paid-in 3,282,402 (6,358,723 ) (3,076,321 ) Retained Earnings 1,716,495 6,358,557 8,075,052 Total Stockholders’ Equity 5,000,003 — 5,000,003 Number of Class A common stock subject to redemption 33,503,505 (1,665,315 ) 31,838,190 Balance sheet as of June 30, 2020 (unaudited) Total Liabilities $ 14,082,333 $ 30,863,750 $ 44,946,083 Class A Common Stock Subject to Possible Redemption 334,879,810 (30,863,750 ) 304,016,060 Class A Common Stock 232 309 541 Additional Paid-in 3,437,641 7,851,734 11,289,375 (Accumulated Deficit) Retained Earnings 1,561,255 (7,852,043 ) (6,290,788 ) Total Stockholders’ Equity 5,000,003 — 5,000,003 Number of Class A common stock subject to redemption 33,487,981 (3,086,375 ) 30,401,606 Balance sheet as of September 30, 2020 (unaudited) Total Liabilities $ 13,252,231 35,173,100 48,425,331 Class A Common Stock Subject to Possible Redemption 334,703,480 (35,173,100 ) 299,530,380 Class A Common Stock 234 352 586 Additional Paid-in 3,613,969 12,161,041 15,775,010 (Accumulated Deficit) Retained Earnings 1,384,926 (12,161,393 ) (10,776,467 ) Total Stockholders’ Equity 5,000,004 — 5,000,004 Number of Class A common stock subject to redemption 33,470,348 (3,517,310 ) 29,953,038 Balance sheet as of December 31, 2020 (audited) Total Liabilities $ 17,639,744 $ 77,419,100 $ 95,058,844 Class A Common Stock Subject to Possible Redemption 329,968,280 (77,419,100 ) 252,549,180 Class A Common Stock 281 775 1,056 Additional Paid-in 8,349,122 54,406,617 62,755,739 Accumulated Deficit (3,350,275 ) (54,407,392 ) (57,757,667 ) Total Stockholders’ Equity 5,000,003 — 5,000,003 Number of Class A common stock subject to redemption 32,996,828 (7,741,910 ) 25,254,918 Three months ended September 30, 2019 (unaudited) Net income (loss) $ 29,595 $ (817,293 ) $ (787,698 ) Weighted average shares outstanding of Class A and Class B non-redeemable 8,855,652 — 8,855,652 Basic and diluted net loss per share, Class A and Class B non-redeemable 0.00 (0.10 ) (0.10 ) Period from April 5, 2019 (inception) to September 30, 2019 (unaudited) Net income (loss) $ 28,595 $ (817,293 ) $ (788,698 ) Weighted average shares outstanding of Class A and Class B non-redeemable 8,804,607 — 8,804,607 Basic and diluted net loss per share, Class A and Class B non-redeemable 0.00 (0.10 ) (0.10 ) Period from April 5, 2019 (inception) to December 31, 2019 (audited) Net income (loss) $ 900,810 $ 2,064,558 $ 2,965,368 Weighted average shares outstanding of Class A and Class B non-redeemable 9,062,000 — 9,062,000 Basic and diluted net loss per share, Class A and Class B non-redeemable (0.03 ) 0.23 0.20 Three months ended March 31, 2020 (unaudited) Net income (loss) $ 815,685 4,294,000 $ 5,109,685 Weighted average shares outstanding of Class A and Class B non-redeemable 9,560,000 — 9,560,000 Basic and diluted net loss per share, Class A and Class B non-redeemable (0.02 ) 0.45 0.43 Three months ended June 30, 2020 (unaudited) Net income (loss) $ (155,240 ) (9,916,600 ) $ (10,071,840 ) Weighted average shares outstanding of Class A and Class B non-redeemable 9,560,000 — 9,560,000 Basic and diluted net loss per share, Class A and Class B non-redeemable (0.02 ) (1.04 ) (1.06 ) Six months ended June 30, 2020 (unaudited) Net income (loss) $ 660,445 $ (9,916,600 ) $ (9,256,155 ) Weighted average shares outstanding of Class A and Class B non-redeemable 9,560,000 — 9,560,000 Basic and diluted net loss per share, Class A and Class B non-redeemable (0.04 ) (1.04 ) (1.08 ) Three months ended September 30, 2020 (unaudited) Net income (loss) (176,329 ) (14,225,950 ) (14,402,279 ) Weighted average shares outstanding of Class A and Class B non-redeemable 9,560,000 — 9,560,000 Basic and diluted net loss per share, Class A and Class B non-redeemable (0.02 ) (1.49 ) (1.51 ) Nine months ended September 30, 2020 (unaudited) Net income (loss) $ 484,116 $ (14,225,950 ) $ (13,741,834 ) Weighted average shares outstanding of Class A and Class B non-redeemable 9,560,000 — 9,560,000 Basic and diluted net loss per share, Class A and Class B non-redeemable (0.06 ) (1.49 ) (1.55 ) Year ended December 31, 2020 (audited) Net income (loss) $ (4,251,085 ) $ (56,471,950 ) $ (60,723,035 ) Weighted average shares outstanding of Class A and Class B non-redeemable 9,560,000 — 9,560,000 Basic and diluted net loss per share, Class A and Class B non-redeemable (0.56 ) (5.90 ) (6.46 )

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q S-X The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K/A 10-K Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future events. Accordingly, the actual results could differ significantly from the Company’s estimates. Cash and cash equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. Cash equivalents are stated at cost, which approximates market value. Cash equivalents consist of money market accounts. As of March 31, 2021 and December 31, 2020, cash equivalents amounted to $50,000. Class A Common Stock Subject to Possible Redemption The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at March 31, 2021 and December 31, 2020, Class A common stock subject to possible redemption is presented as temporary equity, outside of the stockholders’ equity section of the Company’s condensed consolidated balance sheets. Offering Costs Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the balance sheet date that are directly related to the Initial Public Offering. Offering costs amounted to $19,806,442, of which $18,818,200 were charged to stockholders’ equity upon the completion of the Initial Public Offering and $988,242 were charged as transaction costs to the statement of operations. Warrant Liability The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in non-cash Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As of March 31, 2021 and December 31, 2020, the Company had a deferred tax asset of approximately $2,099,000 and $137,000, respectively, which had a full valuation allowance recorded against it of approximately $2,099,000 and $137,000, respectively. The Company’s taxable income primarily consists of interest income on the Trust Account. The Company’s general and administrative costs are generally considered start-up costs and are not currently deductible. The Company did not record an income tax provision during the three months ended March 31, 2021. During the three months ended March 31, 2020, the Company recorded income tax expense of approximately $392,000, primarily related to interest income earned on the Trust Account. The Company’s effective tax rate of 0% and 7% for the three months ended March 31, 2021 and 2020 respectively, differs from the expected income tax rate due to the start-up costs (discussed above) which are not currently deductible. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2021 and December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. Net Income Per Common Share Net income per common share is computed by dividing net income by the weighted average number of common shares outstanding for the period. The Company’s statements of operations includes a presentation of income per share for common shares subject to redemption in a manner similar to the two-class non-redeemable non-redeemable non-redeemable The following table reflects the calculation of basic and diluted net income per share for common shares (in dollars, except per share amounts): Three Months Three Months Redeemable Class A Common Stock Numerator: Earnings allocable to Redeemable Class A Common Stock Interest Income $ 31,841 $ 1,452,414 Income Tax and Franchise Tax (31,841 ) (442,446 ) Net Earnings $ — $ 1,009,968 Denominator: Weighted Average Redeemable Class A Common Stock Redeemable Class A Common Stock, Basic and Diluted 35,000,000 35,000,000 Earnings/Basic and Diluted Redeemable Class A Common Stock $ 0.00 $ 0.03 Non-Redeemable Basic Earnings per Share Numerator: Net Income minus Redeemable Net Earnings Net Income $ 28,311,612 $ 5,109,685 Net Earnings allocable to Redeemable Class A Common Stock — (1,009,968 ) Non-Redeemable $ 28,311,612 $ 4,099,717 Denominator: Weighted Average Non-Redeemable Class A and B Non-Redeemable (1) 9,560,000 9,560,000 Income/Basic Non-Redeemable $ 2.96 $ 0.43 Diluted Loss per Share Numerator: Non-Redeemable Net Income – Basic minus Change in fair value of warrant liabilities Non-Redeemable $ 28,311,612 $ 4,099,717 Less: Change in fair value of warrant liabilities (30,171,850 ) (4,294,000 ) Non-Redeemable $ (1,860,238 ) $ (194,283 ) Denominator: Weighted Average Non-Redeemable Class A and B Non-Redeemable (2) 12,757,321 9,560,000 Loss/Diluted Non-Redeemable $ (0.15 ) $ (0.02 ) (1) The weighted average non-redeemable (2) As of March 31, 2021, diluted weighted average shares outstanding was calculated using the treasury stock method utilizing a weighted average share price of $14.00 and the effect of the warrants sold in the Initial Public Offering and the private placement to purchase an aggregate of 17,905,000 shares. As of March 31, 2020, basic and diluted shares are the same as there are no securities that are dilutive to the Company’s common stockholders. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. At March 31, 2021 and December 31, 2020, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed consolidated balance sheets, primarily due to their short-term nature. Recent Accounting Standards In August 2020, the FASB issued ASU No. 2020-06, “Debt—Debt 470-20) 815-40): 2020-06”), 2020-06 2020-06 2020-06 2020-06 Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed consolidated financial statements.	NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying consolidated financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the “SEC”). Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and its majority owned subsidiary where the Company has the ability to exercise control. All significant intercompany balances and transactions have been eliminated in consolidation. Activities in relation to the noncontrolling interest are not considered to be significant and are, therefore, not presented in the accompanying consolidated financial statements. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future events. Accordingly, the actual results could differ significantly from the Company’s estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2020 and 2019. Class A Common Stock Subject to Possible Redemption The Company accounts for its common stock subject to possible redemption in accordance with the guidance in the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at December 31, 2020 and 2019, Class A common stock subject to possible redemption is presented as temporary equity, outside of the stockholders’ equity section of the Company’s consolidated balance sheets. Offering Costs Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the balance sheet date that are directly related to the Initial Public Offering. Offering costs amounted to $19,806,442, of which $18,818,200 were charged to stockholders’ equity upon the completion of the Initial Public Offering and $988,242 were charged as transaction costs to the statement of operations. Warrant Liability The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in non-cash Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2020 and 2019. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company may be subject to potential examination by foreign taxing authorities in the area of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with foreign tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Net Income (Loss) Per Common Share Net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period. The Company has not considered the effect of warrants sold in the Initial Public Offering and private placement to purchase 17,905,000 shares of Class A common stock in the calculation of diluted income (loss) per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The Company’s statements of operations includes a presentation of income (loss) per share for common shares subject to redemption in a manner similar to the two-class non-redeemable non-redeemable non-redeemable The following table reflects the calculation of basic and diluted net income (loss) per share for common shares (in dollars, except per share amounts): Year Ended For the Redeemable Class A Common Stock Numerator: Earnings allocable to Redeemable Class A Common Stock Interest Income $ 1,671,038 $ 1,809,163 Income Tax and Franchise Tax (612,511 ) (613,244 ) Net Earnings $ 1,058,527 $ 1,195,919 Denominator: Weighted Average Redeemable Class A Common Stock Redeemable Class A Common Stock, Basic and Diluted 35,000,000 35,000,000 Earnings/Basic and Diluted Redeemable Class A Common Stock $ 0.03 $ 0.03 Non-Redeemable Numerator: Net Income minus Redeemable Net Earnings Net (Loss) Income $ (60,723,035 ) $ 2,965,368 Net Earnings applicable to Redeemable Class A Common Stock (1,058,527 ) (1,195,919 ) Non-Redeemable $ (61,781,562 ) $ 1,769,49 Denominator: Weighted Average Non-Redeemable Class A and B Non-Redeemable (1) 9,560,000 9,062,000 Loss/Basic and Diluted Non-Redeemable $ (6.46 ) $ 0.20 Note: As of December 31, 2020 and 2019, basic and diluted shares are the same as there are no securities that are dilutive to the Company’s common stockholders. (1) The weighted average non-redeemable Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. At December 31, 2020 and 2019, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their short-term nature. Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued non-current net-cash Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s consolidated financial statements.

INITIAL PUBLIC OFFERING

INITIAL PUBLIC OFFERING	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Initial Public Offering [Abstract]
INITIAL PUBLIC OFFERING	NOTE 3. INITIAL PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 35,000,000 Units, which includes the partial exercise by the underwriters of its option to purchase an additional 4,500,000 Units, at a price of $10.00 per Unit. Each Unit consists of one share of Class A common stock and one-half	NOTE 4. INITIAL PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 35,000,000 Units, which includes the partial exercise by the underwriters of its option to purchase an additional 4,500,000 Units, at a price of $10.00 per Unit. Each Unit consists of one share of Class A common stock and one-half

PRIVATE PLACEMENT

PRIVATE PLACEMENT	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Private Placement [Abstract]
PRIVATE PLACEMENT	NOTE 4. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Sponsor and Cantor purchased an aggregate of 810,000 Placement Units at a price of $10.00 per Placement Unit, for an aggregate purchase price of $8,100,000, of which the Sponsor purchased 657,500 Placement Units and Cantor purchased 152,500 Placement Units. Each Placement Unit consists of one share of Class A common stock (“Placement Share”) and one-half	NOTE 5. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Sponsor and Cantor purchased an aggregate of 810,000 Placement Units at a price of $10.00 per Placement Unit, for an aggregate purchase price of $8,100,000, of which the Sponsor purchased 657,500 Placement Units and Cantor purchased 152,500 Placement Units. Each Placement Unit consists of one share of Class A common stock (“Placement Share”) and one-half

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares During the period ended December 31, 2019, the Sponsor purchased 7,187,500 shares (the “Founder Shares”) of the Company’s Class B common stock for an aggregate price of $25,000. The Founder Shares will automatically convert into Class A common stock upon consummation of a Business Combination on a one-for-one The Founder Shares included an aggregate of up to 1,143,750 shares subject to forfeiture to the extent that the underwriters’ over-allotment option was not exercised in full or in part, so that the Sponsor would own, on an as-converted The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the last sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading Related Party Loans On June 25, 2019, the Sponsor loaned the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering (the “Promissory Note”). The Promissory Note was non-interest In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into units upon consummation of the Business Combination at a price of $10.00 per unit. The units would be identical to the Placement Units. There are no borrowings outstanding as of March 31, 2021. As of February 3, 2021, the Company issued a convertible promissory note to the Sponsor pursuant to which the Sponsor agreed to loan the Company up to an aggregate principal amount of $300,000 (the “Convertible Promissory Note”). The Convertible Promissory Note is non-interest Administrative Support Agreement The Company entered into an agreement whereby, commencing on September 16, 2019 through the earlier of the Company’s consummation of a Business Combination and its liquidation, the Company will pay an affiliate of the Sponsor a total of $15,000 per month for office space, utilities and secretarial and administrative support. For the three months ended March 31, 2021 and 2020, the Company incurred and paid $45,000 in each three month period in fees for these services.	NOTE 6. RELATED PARTY TRANSACTIONS Founder Shares During the period ended December 31, 2019, the Sponsor purchased 7,187,500 shares (the “Founder Shares”) of the Company’s Class B common stock for an aggregate price of $25,000. The Founder Shares will automatically convert into Class A common stock upon consummation of a Business Combination on a one-for-one The Founder Shares included an aggregate of up to 1,143,750 shares subject to forfeiture to the extent that the underwriters’ over-allotment option was not exercised in full or in part, so that the Sponsor would own, on an as-converted The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the last sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading Related Party Loans On June 25, 2019, the Sponsor loaned the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering (the “Promissory Note”). The Promissory Note was non-interest In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into units upon consummation of the Business Combination at a price of $10.00 per unit. The units would be identical to the Placement Units. There are no borrowings outstanding as of December 31, 2020 and 2019. Administrative Support Agreement The Company entered into an agreement whereby, commencing on September 16, 2019 through the earlier of the Company’s consummation of a Business Combination and its liquidation, the Company will pay an affiliate of the Sponsor a total of $15,000 per month for office space, utilities and secretarial and administrative support. For the year ended December 31, 2020 and for the period from April 5, 2019 (inception) through December 31, 2019, the Company incurred and paid $180,000 and $50,500 in fees for these services, respectively.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 6. COMMITMENTS AND CONTINGENCIES Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 Registration Rights Pursuant to a registration rights agreement entered into on September 16, 2019, the holders of the Founder Shares, Placement Units (including securities contained therein) and units (including securities contained therein) that may be issued upon conversion of Working Capital Loans (and any shares of Class A common stock issuable upon the exercise of the Placement Warrants) and any shares of Class A common stock and warrants (and underlying Class A common stock) that may be issued upon conversion of units issued upon conversion of the Working Capital Loans and Class A common stock issuable upon conversion of the Founder Shares will be entitled to registration rights requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to Class A common stock). The holders of the majority of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. Notwithstanding the foregoing, Cantor may not exercise its demand and “piggyback” registration rights after five (5) and seven (7) years after the effective date of the registration statement and may not exercise its demand rights on more than one occasion. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 45-day The underwriters were paid a cash underwriting discount of $0.20 per Unit or $6,100,000 in the aggregate at the closing of the Initial Public Offering. In addition, the underwriters are entitled to a deferred fee of $13,150,000. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Business Combination Agreement On November 23, 2020, the Company entered into an Agreement and Plan of Merger (the “Business Combination Agreement”) by and among the Company, Athena Technology Merger Sub, Inc., a Delaware corporation (“Merger Sub 1”), Athena Technology Merger Sub 2, LLC, a Delaware limited liability company (“Merger Sub 2”), and AvePoint, relating to a proposed business combination transaction between the Company and AvePoint. The Business Combination Agreement was amended on December 30, 2020, March 8, 2021 and May 18, 2021. Pursuant to the Business Combination Agreement, Merger Sub 1 will be merged with and into AvePoint (the “First Merger”), with AvePoint surviving the First Merger as a wholly owned subsidiary of the Company, and promptly following the First Merger, AvePoint will be merged with and into Merger Sub 2 (the “Second Merger”), with Merger Sub 2 surviving the Second Merger as a wholly owned subsidiary of the Company. Pursuant to the terms of the Business Combination Agreement, at the effective time of the Merger: (a) The aggregate consideration to be paid to AvePoint equity shareholders will be (i) an amount in cash of approximately $263 million (the “Aggregate Cash Consideration”), minus a deduction for the PIPE Fees and (ii) 143,210,835 shares of common stock of the Company (“Apex Common Stock”), which includes shares of Apex Common Stock that may be issuable pursuant to the exercise of exchanged AvePoint stock options (such aggregate amount, the “Aggregate Stock Consideration”). The Aggregate Stock Consideration will be increased by a number of shares of Apex Common Stock equal to the aggregate exercise price of the Exchanged Options divided by $10.00; (b) AvePoint’s stockholders who hold shares of Series C Preferred Stock, par value $0.001 (“AvePoint Preferred Stock”) will receive an aggregate amount of $135 million (subject to deduction for Preferred PIPE Fees) from the Aggregate Cash Consideration and will receive the balance of their consideration in shares of Apex Common Stock from the Aggregate Stock Consideration; (c) All holders of shares of common stock of AvePoint, par value $0.001 per share (“AvePoint Common Stock”) other than the Named Executives will receive an aggregate amount of between $75 million and approximately $93 million in cash (subject to deduction for certain expenses) based on an election (“Cash Election”) from the balance of the Aggregate Cash Consideration and will receive the remainder of their consideration in shares of Apex Common Stock from the Aggregate Stock Consideration; (d) All shares of AvePoint Common Stock and AvePoint Preferred Stock held in the treasury of AvePoint or by the Company shall be canceled without any conversion thereof and no payment or distribution shall be made with respect thereto; (e) Each share of common stock of Merger Sub 1 issued and outstanding immediately prior to the Effective Time shall be converted into and exchanged for one validly issued, fully paid and non-assessable (f) Each Named Executive Cash-Settled Option that is outstanding immediately prior to the Effective Time, shall be converted into the right to receive (A) an amount of cash equal to: the product of (1) the number of Named Executive Cash-Settled Options multiplied by (2) the Per Share Amount, minus (y) the aggregate exercise price attributable to such Named Executive Cash-Settled Options; and (B) the contingent right to receive a number of shares Contingent Consideration following the Closing in accordance with the Business Combination Agreement; (g) The Named Executives will receive an aggregate amount of $35 million in cash (subject to deduction for the Named Executive PIPE Fees (as defined in the Business Combination Agreement)) from the Aggregate Cash Consideration and will receive the balance of their transaction consideration in shares of Apex Common Stock from the Aggregate Stock Consideration; (h) Each AvePoint Option that is outstanding immediately prior to the Effective Time, whether vested or unvested (other than the Named Executive Cash-Settled Options and AvePoint Options granted to Eligible individuals in the People’s Republic of China (“PRC Options”)), shall be converted into (1) an option to purchase a number of shares of Apex Common Stock (such option, an “Exchanged Option”) equal to the product (rounded down to the nearest whole number) of (x) the number of shares of AvePoint Common Stock subject to such AvePoint Option immediately prior to the Effective Time and (y) the Exchange Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such AvePoint Option immediately prior to the Effective Time divided by (B) the Exchange Ratio; and (i) The PRC Options will not be continued or assumed by AvePoint, Apex or the Merger Subs as part of the Mergers. The cancelled PRC Options will be replaced and substituted for as of the Effective Time with the award of a new stock option to purchase a number of shares of Apex Common Stock pursuant to the 2021 Plan equal to the product (rounded down to the nearest whole number) of (x) the number of shares of AvePoint Common Stock subject to such PRC Option immediately prior to the Effective Time and (y) the Exchange Ratio, at an exercise price (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such PRC Option prior to the Effective Time divided by (B) the Exchange Ratio. The replacement stock options will be credited with vesting to the same extent as the existing PRC Options being replaced, and the new replacement awards will be subject to same vesting schedule and exercisability provisions Additionally, On November 23, 2020, the Company entered into separate subscription agreements (collectively, the “Subscription Agreements”) with a number of investors (collectively, the “PIPE Investors”), pursuant to which the PIPE Investors agreed to purchase an aggregate of 14,000,000 shares of Apex Common Stock (the “PIPE Shares”), at a purchase price of $10.00 per share for an aggregate purchase price of $140,000,000, in one or more private placement transactions (the “Private Placements”). The closing of the Private Placements pursuant to the Subscription Agreements is contingent upon, among other customary closing conditions, the concurrent consummation of the Proposed Transactions. The purpose of the Private Placements is to raise additional capital for use by the combined company following the Closing. Following the Closing, in addition to the Aggregate Cash Consideration and Aggregate Stock Consideration, the holders of AvePoint Preferred Stock, AvePoint Common Stock and AvePoint Options shall be issued additional shares of Apex Common Stock, as follows: (a) 1,000,000 shares of Apex Common Stock, in the aggregate, if at any time from and after the Closing through the seventh anniversary thereof (x) the Closing Price is greater than or equal to $12.50 over any 20 Trading Days within any 30 Trading Day period or (y) Apex consummates a Subsequent Transaction, which results in the stockholders of Apex having the right to exchange their shares for cash, securities or other property having a value equaling or exceeding $12.50 per share (the “First Milestone”) (such 1,000,000 shares of Apex Common Stock, the “First Milestone Contingent Consideration”); (b) 1,000,000 shares of Apex Common Stock, in the aggregate, if at any time from and after the Closing through the seventh anniversary thereof (x) the Closing Price is greater than or equal to $15.00 over any 20 Trading Days within any 30 Trading Day period or (y) Apex consummates a Subsequent Transaction, which results in the stockholders of Apex having the right to exchange their shares for cash, securities or other property having a value equaling or exceeding $15.00 per share (the “Second Milestone”) (such 1,000,000 shares of Apex Common Stock, the “Second Milestone Contingent Consideration”); and (c) 1,000,000 shares of Apex Common Stock, in the aggregate, if at any time from and after the Closing through the seventh anniversary thereof (x) the Closing Price is greater than or equal to $17.50 over any 20 Trading Days within any 30 Trading Day period or (y) Apex consummates a Subsequent Transaction, which results in the stockholders of Apex having the right to exchange their shares for cash, securities or other property having a value equaling or exceeding $17.50 per share (the “Third Milestone”) (such 1,000,000 shares of Apex Common Stock, the “Third Milestone Contingent Consideration” and together with the First Milestone Contingent Consideration and the Second Milestone Contingent Consideration, the “Contingent Consideration”). For the avoidance of doubt, the maximum amount of the Contingent Consideration is 3,000,000 shares of Apex Common Stock, in the aggregate. The parties to the Business Combination Agreement have made customary representations, warranties and covenants, including, among others, with respect to the conduct of the businesses of AvePoint and Apex during the period between execution of the Business Combination Agreement and the consummation of the Business Combination.	NOTE 7. COMMITMENTS AND CONTINGENCIES Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 Registration Rights Pursuant to a registration rights agreement entered into on September 16, 2019, the holders of the Founder Shares, Placement Units (including securities contained therein) and units (including securities contained therein) that may be issued upon conversion of Working Capital Loans (and any shares of Class A common stock issuable upon the exercise of the Placement Warrants) and any shares of Class A common stock and warrants (and underlying Class A common stock) that may be issued upon conversion of units issued upon conversion of the Working Capital Loans and Class A common stock issuable upon conversion of the Founder Shares will be entitled to registration rights requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to Class A common stock). The holders of the majority of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. Notwithstanding the foregoing, Cantor may not exercise its demand and “piggyback” registration rights after five (5) and seven (7) years after the effective date of the registration statement and may not exercise its demand rights on more than one occasion. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 45-day The underwriters were paid a cash underwriting discount of $0.20 per Unit or $6,100,000 in the aggregate at the closing of the Initial Public Offering. In addition, the underwriters are entitled to a deferred fee of $13,150,000. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Business Combination Agreement On November 23, 2020, the Company entered into an Agreement and Plan of Merger (the “Business Combination Agreement”) by and among the Company, Athena Technology Merger Sub, Inc., a Delaware corporation (“Merger Sub 1”), Athena Technology Merger Sub 2, LLC, a Delaware limited liability company (“Merger Sub 2”), and AvePoint, relating to a proposed business combination transaction between the Company and AvePoint. The Business Combination Agreement was amended on December 30, 2020, March 8, 2021 and May 18, 2021. Pursuant to the Business Combination Agreement, Merger Sub 1 will be merged with and into AvePoint (the “First Merger”), with AvePoint surviving the First Merger as a wholly owned subsidiary of the Company, and promptly following the First Merger, AvePoint will be merged with and into Merger Sub 2 (the “Second Merger”), with Merger Sub 2 surviving the Second Merger as a wholly owned subsidiary of the Company. Pursuant to the terms of the Business Combination Agreement, at the effective time of the Merger: (a) The aggregate consideration to be paid to AvePoint equity shareholders will be (i) an amount in cash of approximately $262 million (the “Aggregate Cash Consideration”), minus a deduction for the PIPE Fees and (ii) 143,261,093 shares of common stock of Apex, par value $0.0001 (“Apex Common Stock”), which includes shares of Apex Common Stock that may be issuable pursuant to the exercise of exchanged AvePoint stock options (such aggregate amount, the “Aggregate Stock Consideration”). The Aggregate Stock Consideration will be increased by a number of shares of Apex Common Stock equal to the aggregate exercise price of the Exchanged Options divided by $10.00; (b) AvePoint’s stockholders who hold shares of Series C Preferred Stock, par value $0.001 (“AvePoint Preferred Stock”) will receive an aggregate amount of $135 million (subject to deduction for Preferred PIPE Fees) from the Aggregate Cash Consideration and will receive the balance of their consideration in shares of Apex Common Stock from the Aggregate Stock Consideration; (c) All holders of shares of common stock of AvePoint, par value $0.001 per share (“AvePoint Common Stock”) other than the Named Executives will receive an aggregate amount of between $75 million and approximately $92 million in cash (subject to deduction for certain expenses) based on an election (“Cash Election”) from the balance of the Aggregate Cash Consideration and will receive the remainder of their consideration in shares of Apex Common Stock from the Aggregate Stock Consideration; (d) All shares of AvePoint Common Stock and AvePoint Preferred Stock held in the treasury of AvePoint or by Apex shall be canceled without any conversion thereof and no payment or distribution shall be made with respect thereto; (e) Each share of common stock of Merger Sub 1 issued and outstanding immediately prior to the Effective Time shall be converted into and exchanged for one validly issued, fully paid and non-assessable (f) Each Named Executive Cash-Settled Option that is outstanding immediately prior to the Effective Time, shall be converted into the right to receive (A) an amount of cash equal to: the product of (1) the number of Named Executive Cash-Settled Options multiplied by (2) the Per Share Amount, minus (y) the aggregate exercise price attributable to such Named Executive Cash-Settled Options; and (B) the contingent right to receive a number of shares Contingent Consideration following the Closing in accordance with the Business Combination Agreement; (g) The Named Executives will receive an aggregate amount of $35 million in cash (subject to deduction for the Named Executive PIPE Fees (as defined in the Business Combination Agreement)) from the Aggregate Cash Consideration and will receive the balance of their transaction consideration in shares of Apex Common Stock from the Aggregate Stock Consideration; (h) Each AvePoint Option that is outstanding immediately prior to the Effective Time, whether vested or unvested (other than the Named Executive Cash-Settled Options and AvePoint Options granted to Eligible individuals in the People’s Republic of China (“PRC Options”)), shall be converted into (1) an option to purchase a number of shares of Apex Common Stock (such option, an “Exchanged Option”) equal to the product (rounded down to the nearest whole number) of (x) the number of shares of AvePoint Common Stock subject to such AvePoint Option immediately prior to the Effective Time and (y) the Exchange Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such AvePoint Option immediately prior to the Effective Time divided by (B) the Exchange Ratio; and (i) The PRC Options will not be continued or assumed by AvePoint, Apex or the Merger Subs as part of the Mergers. The cancelled PRC Options will be replaced and substituted for as of the Effective Time with the award of a new stock option to purchase a number of shares of Apex Common Stock pursuant to the 2021 Plan equal to the product (rounded down to the nearest whole number) of (x) the number of shares of AvePoint Common Stock subject to such PRC Option immediately prior to the Effective Time and (y) the Exchange Ratio, at an exercise price (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such PRC Option prior to the Effective Time divided by (B) the Exchange Ratio. The replacement stock options will be credited with vesting to the same extent as the existing PRC Options being replaced, and the new replacement awards will be subject to same vesting schedule and exercisability provisions Additionally, On November 23, 2020, Apex entered into separate subscription agreements (collectively, the “Subscription Agreements”) with a number of investors (collectively, the “PIPE Investors”), pursuant to which the PIPE Investors agreed to purchase an aggregate of 14,000,000 shares of Apex Common Stock (the “PIPE Shares”), at a purchase price of $10.00 per share for an aggregate purchase price of $140,000,000, in one or more private placement transactions (the “Private Placements”). The closing of the Private Placements pursuant to the Subscription Agreements is contingent upon, among other customary closing conditions, the concurrent consummation of the Proposed Transactions. The purpose of the Private Placements is to raise additional capital for use by the combined company following the Closing. Following the Closing, in addition to the Aggregate Cash Consideration and Aggregate Stock Consideration, the holders of AvePoint Preferred Stock, AvePoint Common Stock and AvePoint Options shall be issued additional shares of Apex Common Stock, as follows: (a) 1,000,000 shares of Apex Common Stock, in the aggregate, if at any time from and after the Closing through the seventh anniversary thereof (x) the Closing Price is greater than or equal to $12.50 over any 20 Trading Days within any 30 Trading Day period or (y) Apex consummates a Subsequent Transaction, which results in the stockholders of Apex having the right to exchange their shares for cash, securities or other property having a value equaling or exceeding $12.50 per share (the “First Milestone”) (such 1,000,000 shares of Apex Common Stock, the “First Milestone Contingent Consideration”); (b) 1,000,000 shares of Apex Common Stock, in the aggregate, if at any time from and after the Closing through the seventh anniversary thereof (x) the Closing Price is greater than or equal to $15.00 over any 20 Trading Days within any 30 Trading Day period or (y) Apex consummates a Subsequent Transaction, which results in the stockholders of Apex having the right to exchange their shares for cash, securities or other property having a value equaling or exceeding $15.00 per share (the “Second Milestone”) (such 1,000,000 shares of Apex Common Stock, the “Second Milestone Contingent Consideration”); and (c) 1,000,000 shares of Apex Common Stock, in the aggregate, if at any time from and after the Closing through the seventh anniversary thereof (x) the Closing Price is greater than or equal to $17.50 over any 20 Trading Days within any 30 Trading Day period or (y) Apex consummates a Subsequent Transaction, which results in the stockholders of Apex having the right to exchange their shares for cash, securities or other property having a value equaling or exceeding $17.50 per share (the “Third Milestone”) (such 1,000,000 shares of Apex Common Stock, the “Third Milestone Contingent Consideration” and together with the First Milestone Contingent Consideration and the Second Milestone Contingent Consideration, the “Contingent Consideration”). For the avoidance of doubt, the maximum amount of the Contingent Consideration is 3,000,000 shares of Apex Common Stock, in the aggregate. The parties to the Business Combination Agreement have made customary representations, warranties and covenants, including, among others, with respect to the conduct of the businesses of AvePoint and Apex during the period between execution of the Business Combination Agreement and the consummation of the Business Combination

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Stockholders Equity Note Abstract
STOCKHOLDERS' EQUITY	NOTE 7. STOCKHOLDERS’ EQUITY Preferred Stock Class A Common Stock Class B Common Stock Holders of Class A common stock and Class B common stock will vote together as a single class on all other matters submitted to a vote of stockholders except as required by law. The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of a Business Combination on a one-for-one as-converted	NOTE 8. STOCKHOLDERS’ EQUITY Preferred Stock Class A Common Stock Class B Common Stock Holders of Class A common stock and Class B common stock will vote together as a single class on all other matters submitted to a vote of stockholders except as required by law. The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of a Business Combination on a one-for-one as-converted

WARRANT LIABILITIES

WARRANT LIABILITIES	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
WARRANT LIABILITIES	NOTE 8. WARRANT LIABILITIES Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the shares of Class A common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable and the Company will not be obligated to issue shares of Class A common stock upon exercise of a warrant unless Class A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of a Business Combination, the Company will use its best efforts to file with the SEC a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants, to cause such registration statement to become effective and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants is not effective by the 60 th Once the warrants become exercisable, the Company may redeem the Public Warrants: • in whole and not in part; • at a price of $0.01 per warrant; • upon not less than 30 days’ prior written notice of redemption given after the warrants become exercisable; and • if, and only if, the reported last sale price of the Company’s Class A common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading If and when the warrants become redeemable by the Company, the Company may not exercise its redemption right if the issuance of shares of common stock upon exercise of the warrants is not exempt from registration or qualification under applicable state blue sky laws or the Company is unable to effect such registration or qualification. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of Class A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of Class A common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the shares of Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates a Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. The Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Placement Warrants and the Class A common stock issuable upon the exercise of the Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Placement Warrants will be exercisable on a cashless basis and be non-redeemable	NOTE 9. WARRANTS Warrants The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the shares of Class A common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable and the Company will not be obligated to issue shares of Class A common stock upon exercise of a warrant unless Class A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of a Business Combination, the Company will use its best efforts to file with the SEC a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants, to cause such registration statement to become effective and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants is not effective by the 60th business day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the foregoing, if a registration statement covering the Class A common stock issuable upon exercise of the warrants is not effective within a specified period following the consummation of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. Once the warrants become exercisable, the Company may redeem the Public Warrants: • in whole and not in part; • at a price of $0.01 per warrant; • upon not less than 30 days’ prior written notice of redemption given after the warrants become exercisable; and • if, and only if, the reported last sale price of the Company’s Class A common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading If and when the warrants become redeemable by the Company, the Company may not exercise its redemption right if the issuance of shares of common stock upon exercise of the warrants is not exempt from registration or qualification under applicable state blue sky laws or the Company is unable to effect such registration or qualification. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of Class A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of Class A common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the shares of Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates a Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. The Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Placement Warrants and the Class A common stock issuable upon the exercise of the Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Placement Warrants will be exercisable on a cashless basis and be non-redeemable

INCOME TAX

INCOME TAX	12 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
INCOME TAX	NOTE 10. INCOME TAX The Company’s net deferred tax assets are as follows: As of December 31, 2020 2019 Deferred tax asset Organizational costs/Startup expenses $ 1,568,202 $ 61,973 Total deferred tax asset 1,568,202 61,973 Valuation allowance (1,568,202 ) (61,973 ) Deferred tax asset, net of allowance $ — $ — The income tax provision consists of the following: As of December 31, 2020 2019 Federal Current $ 281,381 $ 317,902 Deferred (1,115,020 ) (61,973 ) State Current $ 129,934 $ — Deferred (391,209 ) — Change in valuation allowance 1,506,229 61,973 Income tax provision $ 411,315 $ 317,902 As of December 31, 2020 and 2019, the Company did not have any U.S. federal and state net operating loss carryovers available to offset future taxable income. In assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the year ended December 31, 2020 and for the period from April 5, 2019 (inception) through December 31, 2019, the change in the valuation allowance was $1,506,229 and $61,973, respectively. A reconciliation of the federal income tax rate to the Company’s effective tax rate is as follows: As of December 31, 2020 2019 Statutory federal income tax rate 21.0 % 21.0 % State taxes, net of federal tax benefit 7.0 % 0.0 % Change in fair value of warrant liability (26.2 )% 0.0 % Change in valuation allowance (2.5 )% 5.1 % Income tax provision (0.7 )% 26.1 % The Company files income tax returns in the U.S. federal jurisdiction in various state and local jurisdictions and is subject to examination by the various taxing authorities for 2019 and 2020.

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	NOTE 9. FAIR VALUE MEASUREMENTS The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured non-financial re-measured The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. The Company classifies its U.S. Treasury and equivalent securities as held-to-maturity Held-to-maturity Held-to-maturity At March 31, 2021, assets held in the Trust Account were comprised of $680 in cash and $351,889,481 in money market funds, which are invested in U.S. Treasury Securities. At December 31, 2020, assets held in the Trust Account were comprised of $1,455 in cash and $175,325,383 in money market funds, which are invested in U.S. Treasury Securities and $176,531,482 in U.S. Treasury Bills. During the three months ended March 31, 2021, the Company did not withdraw any interest income on the Trust Account. During the three months ended March 31, 2020, the Company withdrew $148,743 of interest earned on the Trust Account to pay its franchise taxes. The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at March 31, 2021 and December 31, 2020 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level March 31, December 31, Assets: Investments – U.S. Treasury Securities Money Market Fund 1 $ 351,889,481 $ 175,325,383 Liabilities: Warrant Liability – Public Warrants 1 45,850,000 74,900,000 Warrant Liability – Private Placement Warrants 3 1,397,250 2,519,100 The Warrants were accounted for as liabilities in accordance with ASC 815-40 The Warrants were valued using a Modified Black Scholes Option Pricing Model, which is considered to be a Level 3 fair value measurement. The Modified Black Scholes model’s primary unobservable input utilized in determining the fair value of the Warrants is the expected volatility of the common stock. The expected volatility as of the date of the Initial Public Offering date was derived from observable public warrant pricing on comparable ‘blank-check’ companies without an identified target. The expected volatility as of subsequent valuation dates was estimated through comparable guideline companies. The key inputs into the Modified Black-Scholes Option Pricing Model for the Warrants were as follows: Input: March 31, December 31, Risk-free interest rate 0.95 % 0.42 % Expected term (years) 5.1 5.4 Expected volatility 34.8 % 34.5 % Exercise price $ 11.50 $ 11.50 Fair value of Units $ 11.08 $ 15.01 The following table presents the changes in the fair value of warrant liabilities: Private Placement Public Warrant Liabilities Fair value as of January 1, 2021 $ 2,519,000 $ 74,900,000 $ 77,419,100 Change in valuation inputs or other assumptions (1) (1,121,850 ) (29,050,000 ) (30,171,850 ) Fair value as of March 31, 2021 $ 1,397,250 $ 45,850,000 $ 47,247,250 (1) Changes in valuation inputs or other assumptions are recognized in change in fair value of warrant liabilities in the consolidated statement of operations. There were no transfers in or out of Level 3 from other levels in the fair value hierarchy.	NOTE 11. FAIR VALUE MEASUREMENTS The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured non-financial re-measured The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. The Company classifies its U.S. Treasury and equivalent securities as held-to-maturity Held-to-maturity Held-to-maturity At December 31, 2020, assets held in the Trust Account were comprised of $1,455 in cash and $175,325,383 in money market funds, which are invested in U.S. Treasury Securities and $176,531,482 in U.S. Treasury Bills. At December 31, 2019, assets held in the Trust Account were comprised of $532 in cash, $94,650 in money market funds, which are invested in U.S. Treasury Securities, and $351,713,981 in U.S. Treasury Bills. During the year ended December 31, 2020, the Company withdrew $1,621,881 of interest earned on the Trust Account to pay its franchise and income taxes. During the period ended December 31, 2019, the Company did not withdraw any interest income from the Trust Account to pay its taxes. The gross holding losses and fair value of held-to-maturity Held-To-Maturity Amortized Cost Gross Holding Fair Value December 31, 2020 U.S. Treasury Securities $ 176,531,482 $ 2,987 $ 176,534,469 December 31, 2019 U.S. Treasury Securities $ 351,713,981 $ 281,644 $ 351,995,625 The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at December 31, 2020 and 2019 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level December 31, December 31, Assets: Investments – U.S. Treasury Securities Money Market Fund 1 $ 175,325,383 $ 94,650 Liabilities: Warrant Liability – Public Warrants 1 74,900,000 20,125,000 Warrant Liability – Private Placement Warrants 3 2,519,100 822,150 The Warrants were accounted for as liabilities in accordance with ASC 815-40 The Private Warrants were initially valued using a Modified Black Scholes Option Pricing Model, which is considered to be a Level 3 fair value measurement. The Modified Black Scholes model’s primary unobservable input utilized in determining the fair value of the Private Warrants is the expected volatility of the common stock. The expected volatility as of the Initial Public Offering date was derived from observable public warrant pricing on comparable ‘blank-check’ companies without an identified target. The expected volatility as of subsequent valuation dates was implied from the Company’s own public warrant pricing. A Monte Carlo simulation methodology was used in estimating the fair value of the public warrants for periods where no observable traded price was available, using the same expected volatility as was used in measuring the fair value of the Private Warrants. For periods subsequent to the detachment of the warrants from the Units, the closing price of the Public Warrant was used as the fair value as of each relevant date. The following table presents the changes in the fair value of Level 3 warrant liabilities: Private Placement Public Warrant Liabilities (Level 3) Fair value as of April 5, 2019 (inception) $ — $ — $ — Initial measurement on September 19, 2019 724,950 23,275,000 23,299,950 Change in valuation inputs or other assumptions 97,200 (175,000 ) (77,800 ) Transfer from Level 3 to Level 2 measurement — (23,100,000 ) (23,100,000 ) Fair value as of December 31, 2019 822,150 — 82,500 Change in valuation inputs or other assumptions (1) 1,696,950 — 1,696,950 Fair value as of December 31, 2020 2,519,000 — 2,519,000 (1) Due to the use of quoted prices in an active market (Level 1) to measure the fair value of the Public Warrants, subsequent to initial measurement, the Company had transfers out of Level 3 totaling $23,100,000 during the period from April 5, 2019 through December 31, 2019.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 9. SUBSEQUENT EVENTS The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the condensed consolidated financial statements were issued. Based upon this review, the Company did not identify subsequent events that would have required adjustment or disclosure in the condensed consolidated financial statements.	NOTE 12. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the consolidated financial statements were issued. Based upon this review other than as described in footnote 2, the Company did not identify any subsequent events that would have required adjustment or disclosure in the consolidated financial statements.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q S-X The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K/A 10-K	Basis of Presentation The accompanying consolidated financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the “SEC”).
Principles of Consolidation	Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.	Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and its majority owned subsidiary where the Company has the ability to exercise control. All significant intercompany balances and transactions have been eliminated in consolidation. Activities in relation to the noncontrolling interest are not considered to be significant and are, therefore, not presented in the accompanying consolidated financial statements.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future events. Accordingly, the actual results could differ significantly from the Company’s estimates.	Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future events. Accordingly, the actual results could differ significantly from the Company’s estimates.
Cash and cash equivalents	Cash and cash equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. Cash equivalents are stated at cost, which approximates market value. Cash equivalents consist of money market accounts. As of March 31, 2021 and December 31, 2020, cash equivalents amounted to $50,000.	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2020 and 2019.
Class A Common Stock Subject to Possible Redemption	Class A Common Stock Subject to Possible Redemption The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at March 31, 2021 and December 31, 2020, Class A common stock subject to possible redemption is presented as temporary equity, outside of the stockholders’ equity section of the Company’s condensed consolidated balance sheets.	Class A Common Stock Subject to Possible Redemption The Company accounts for its common stock subject to possible redemption in accordance with the guidance in the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at December 31, 2020 and 2019, Class A common stock subject to possible redemption is presented as temporary equity, outside of the stockholders’ equity section of the Company’s consolidated balance sheets.
Offering Costs	Offering Costs Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the balance sheet date that are directly related to the Initial Public Offering. Offering costs amounted to $19,806,442, of which $18,818,200 were charged to stockholders’ equity upon the completion of the Initial Public Offering and $988,242 were charged as transaction costs to the statement of operations.	Offering Costs Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the balance sheet date that are directly related to the Initial Public Offering. Offering costs amounted to $19,806,442, of which $18,818,200 were charged to stockholders’ equity upon the completion of the Initial Public Offering and $988,242 were charged as transaction costs to the statement of operations.
Warrant Liability	Warrant Liability The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in non-cash	Warrant Liability The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in non-cash
Income Taxes	Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As of March 31, 2021 and December 31, 2020, the Company had a deferred tax asset of approximately $2,099,000 and $137,000, respectively, which had a full valuation allowance recorded against it of approximately $2,099,000 and $137,000, respectively. The Company’s taxable income primarily consists of interest income on the Trust Account. The Company’s general and administrative costs are generally considered start-up costs and are not currently deductible. The Company did not record an income tax provision during the three months ended March 31, 2021. During the three months ended March 31, 2020, the Company recorded income tax expense of approximately $392,000, primarily related to interest income earned on the Trust Account. The Company’s effective tax rate of 0% and 7% for the three months ended March 31, 2021 and 2020 respectively, differs from the expected income tax rate due to the start-up costs (discussed above) which are not currently deductible. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2021 and December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.	Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2020 and 2019. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company may be subject to potential examination by foreign taxing authorities in the area of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with foreign tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Net Income (Loss) Per Common Share	Net Income Per Common Share Net income per common share is computed by dividing net income by the weighted average number of common shares outstanding for the period. The Company’s statements of operations includes a presentation of income per share for common shares subject to redemption in a manner similar to the two-class non-redeemable non-redeemable non-redeemable The following table reflects the calculation of basic and diluted net income per share for common shares (in dollars, except per share amounts): Three Months Three Months Redeemable Class A Common Stock Numerator: Earnings allocable to Redeemable Class A Common Stock Interest Income $ 31,841 $ 1,452,414 Income Tax and Franchise Tax (31,841 ) (442,446 ) Net Earnings $ — $ 1,009,968 Denominator: Weighted Average Redeemable Class A Common Stock Redeemable Class A Common Stock, Basic and Diluted 35,000,000 35,000,000 Earnings/Basic and Diluted Redeemable Class A Common Stock $ 0.00 $ 0.03 Non-Redeemable Basic Earnings per Share Numerator: Net Income minus Redeemable Net Earnings Net Income $ 28,311,612 $ 5,109,685 Net Earnings allocable to Redeemable Class A Common Stock — (1,009,968 ) Non-Redeemable $ 28,311,612 $ 4,099,717 Denominator: Weighted Average Non-Redeemable Class A and B Non-Redeemable (1) 9,560,000 9,560,000 Income/Basic Non-Redeemable $ 2.96 $ 0.43 Diluted Loss per Share Numerator: Non-Redeemable Net Income – Basic minus Change in fair value of warrant liabilities Non-Redeemable $ 28,311,612 $ 4,099,717 Less: Change in fair value of warrant liabilities (30,171,850 ) (4,294,000 ) Non-Redeemable $ (1,860,238 ) $ (194,283 ) Denominator: Weighted Average Non-Redeemable Class A and B Non-Redeemable (2) 12,757,321 9,560,000 Loss/Diluted Non-Redeemable $ (0.15 ) $ (0.02 ) (1) The weighted average non-redeemable (2) As of March 31, 2021, diluted weighted average shares outstanding was calculated using the treasury stock method utilizing a weighted average share price of $14.00 and the effect of the warrants sold in the Initial Public Offering and the private placement to purchase an aggregate of 17,905,000 shares. As of March 31, 2020, basic and diluted shares are the same as there are no securities that are dilutive to the Company’s common stockholders.	Net Income (Loss) Per Common Share Net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period. The Company has not considered the effect of warrants sold in the Initial Public Offering and private placement to purchase 17,905,000 shares of Class A common stock in the calculation of diluted income (loss) per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The Company’s statements of operations includes a presentation of income (loss) per share for common shares subject to redemption in a manner similar to the two-class non-redeemable non-redeemable non-redeemable The following table reflects the calculation of basic and diluted net income (loss) per share for common shares (in dollars, except per share amounts): Year Ended For the Redeemable Class A Common Stock Numerator: Earnings allocable to Redeemable Class A Common Stock Interest Income $ 1,671,038 $ 1,809,163 Income Tax and Franchise Tax (612,511 ) (613,244 ) Net Earnings $ 1,058,527 $ 1,195,919 Denominator: Weighted Average Redeemable Class A Common Stock Redeemable Class A Common Stock, Basic and Diluted 35,000,000 35,000,000 Earnings/Basic and Diluted Redeemable Class A Common Stock $ 0.03 $ 0.03 Non-Redeemable Numerator: Net Income minus Redeemable Net Earnings Net (Loss) Income $ (60,723,035 ) $ 2,965,368 Net Earnings applicable to Redeemable Class A Common Stock (1,058,527 ) (1,195,919 ) Non-Redeemable $ (61,781,562 ) $ 1,769,49 Denominator: Weighted Average Non-Redeemable Class A and B Non-Redeemable (1) 9,560,000 9,062,000 Loss/Basic and Diluted Non-Redeemable $ (6.46 ) $ 0.20 Note: As of December 31, 2020 and 2019, basic and diluted shares are the same as there are no securities that are dilutive to the Company’s common stockholders. (1) The weighted average non-redeemable
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. At March 31, 2021 and December 31, 2020, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. At December 31, 2020 and 2019, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed consolidated balance sheets, primarily due to their short-term nature.	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their short-term nature.
Fair Value Measurements		Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Derivative Financial Instruments		Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued non-current net-cash
Recent Accounting Standards	Recent Accounting Standards In August 2020, the FASB issued ASU No. 2020-06, “Debt—Debt 470-20) 815-40): 2020-06”), 2020-06 2020-06 2020-06 2020-06 Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed consolidated financial statements.	Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s consolidated financial statements.

RESTATEMENT OF PREVIOUSLY ISS_2

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)	12 Months Ended
	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of financial statements of balance sheet, income statement	As Previously Adjustments As Restated Balance sheet as of September 19, 2019 (audited) Total Liabilities $ 13,150,815 $ 23,999,950 $ 37,150,765 Class A Common Stock Subject to Possible Redemption 333,314,490 (23,999,950 ) 309,314,540 Class A Common Stock 248 240 488 Additional Paid-in 5,002,945 988,003 5,990,948 Accumulated Deficit (4,065 ) (988,243 ) (992,308 ) Total Stockholders’ Equity 5,000,003 — 5,000,003 Number of Class A common stock subject to redemption 33,331,449 (2,399,995 ) 30,931,454 Balance sheet as of September 30, 2019 (unaudited) Total Liabilities $ 13,284,099 $ 23,829,000 $ 37,113,099 Class A Common Stock Subject to Possible Redemption 333,347,150 (23,829,000 ) 309,518,150 Class A Common Stock 248 238 486 Additional Paid-in 4,970,285 817,055 5,787,340 (Accumulated Deficit) Retained Earnings 28,595 (817,293 ) (788,698 ) Total Stockholders’ Equity 5,000,003 — 5,000,003 Number of Class A common stock subject to redemption 33,334,715 (2,382,900 ) 30,951,815 Balance sheet as of December 31, 2019 (audited) Total Liabilities $ 13,768,244 $ 20,947,150 $ 34,715,394 Class A Common Stock Subject to Possible Redemption 334,219,360 (20,947,150 ) 313,272,210 Class A Common Stock 239 209 448 Additional Paid-in 4,098,084 (2,064,767 ) 2,033,317 Retained Earnings 900,810 2,064,558 2,965,368 Total Stockholders’ Equity 5,000,008 — 5,000,008 Number of Class A common stock subject to redemption 33,421,936 (2,094,715 ) 31,327,221 Balance sheet as of March 31, 2020 (unaudited) Total Liabilities $ 14,063,126 $ 16,653,150 $ 30,716,276 Class A Common Stock Subject to Possible Redemption 335,035,050 (16,653,150 ) 318,381,900 Class A Common Stock 231 166 397 Additional Paid-in 3,282,402 (6,358,723 ) (3,076,321 ) Retained Earnings 1,716,495 6,358,557 8,075,052 Total Stockholders’ Equity 5,000,003 — 5,000,003 Number of Class A common stock subject to redemption 33,503,505 (1,665,315 ) 31,838,190 Balance sheet as of June 30, 2020 (unaudited) Total Liabilities $ 14,082,333 $ 30,863,750 $ 44,946,083 Class A Common Stock Subject to Possible Redemption 334,879,810 (30,863,750 ) 304,016,060 Class A Common Stock 232 309 541 Additional Paid-in 3,437,641 7,851,734 11,289,375 (Accumulated Deficit) Retained Earnings 1,561,255 (7,852,043 ) (6,290,788 ) Total Stockholders’ Equity 5,000,003 — 5,000,003 Number of Class A common stock subject to redemption 33,487,981 (3,086,375 ) 30,401,606 Balance sheet as of September 30, 2020 (unaudited) Total Liabilities $ 13,252,231 35,173,100 48,425,331 Class A Common Stock Subject to Possible Redemption 334,703,480 (35,173,100 ) 299,530,380 Class A Common Stock 234 352 586 Additional Paid-in 3,613,969 12,161,041 15,775,010 (Accumulated Deficit) Retained Earnings 1,384,926 (12,161,393 ) (10,776,467 ) Total Stockholders’ Equity 5,000,004 — 5,000,004 Number of Class A common stock subject to redemption 33,470,348 (3,517,310 ) 29,953,038 Balance sheet as of December 31, 2020 (audited) Total Liabilities $ 17,639,744 $ 77,419,100 $ 95,058,844 Class A Common Stock Subject to Possible Redemption 329,968,280 (77,419,100 ) 252,549,180 Class A Common Stock 281 775 1,056 Additional Paid-in 8,349,122 54,406,617 62,755,739 Accumulated Deficit (3,350,275 ) (54,407,392 ) (57,757,667 ) Total Stockholders’ Equity 5,000,003 — 5,000,003 Number of Class A common stock subject to redemption 32,996,828 (7,741,910 ) 25,254,918 Three months ended September 30, 2019 (unaudited) Net income (loss) $ 29,595 $ (817,293 ) $ (787,698 ) Weighted average shares outstanding of Class A and Class B non-redeemable 8,855,652 — 8,855,652 Basic and diluted net loss per share, Class A and Class B non-redeemable 0.00 (0.10 ) (0.10 ) Period from April 5, 2019 (inception) to September 30, 2019 (unaudited) Net income (loss) $ 28,595 $ (817,293 ) $ (788,698 ) Weighted average shares outstanding of Class A and Class B non-redeemable 8,804,607 — 8,804,607 Basic and diluted net loss per share, Class A and Class B non-redeemable 0.00 (0.10 ) (0.10 ) Period from April 5, 2019 (inception) to December 31, 2019 (audited) Net income (loss) $ 900,810 $ 2,064,558 $ 2,965,368 Weighted average shares outstanding of Class A and Class B non-redeemable 9,062,000 — 9,062,000 Basic and diluted net loss per share, Class A and Class B non-redeemable (0.03 ) 0.23 0.20 Three months ended March 31, 2020 (unaudited) Net income (loss) $ 815,685 4,294,000 $ 5,109,685 Weighted average shares outstanding of Class A and Class B non-redeemable 9,560,000 — 9,560,000 Basic and diluted net loss per share, Class A and Class B non-redeemable (0.02 ) 0.45 0.43 Three months ended June 30, 2020 (unaudited) Net income (loss) $ (155,240 ) (9,916,600 ) $ (10,071,840 ) Weighted average shares outstanding of Class A and Class B non-redeemable 9,560,000 — 9,560,000 Basic and diluted net loss per share, Class A and Class B non-redeemable (0.02 ) (1.04 ) (1.06 ) Six months ended June 30, 2020 (unaudited) Net income (loss) $ 660,445 $ (9,916,600 ) $ (9,256,155 ) Weighted average shares outstanding of Class A and Class B non-redeemable 9,560,000 — 9,560,000 Basic and diluted net loss per share, Class A and Class B non-redeemable (0.04 ) (1.04 ) (1.08 ) Three months ended September 30, 2020 (unaudited) Net income (loss) (176,329 ) (14,225,950 ) (14,402,279 ) Weighted average shares outstanding of Class A and Class B non-redeemable 9,560,000 — 9,560,000 Basic and diluted net loss per share, Class A and Class B non-redeemable (0.02 ) (1.49 ) (1.51 ) Nine months ended September 30, 2020 (unaudited) Net income (loss) $ 484,116 $ (14,225,950 ) $ (13,741,834 ) Weighted average shares outstanding of Class A and Class B non-redeemable 9,560,000 — 9,560,000 Basic and diluted net loss per share, Class A and Class B non-redeemable (0.06 ) (1.49 ) (1.55 ) Year ended December 31, 2020 (audited) Net income (loss) $ (4,251,085 ) $ (56,471,950 ) $ (60,723,035 ) Weighted average shares outstanding of Class A and Class B non-redeemable 9,560,000 — 9,560,000 Basic and diluted net loss per share, Class A and Class B non-redeemable (0.56 ) (5.90 ) (6.46 )

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Accounting Policies [Abstract]
Schedule of basic and diluted net income (loss) per share for common shares	The following table reflects the calculation of basic and diluted net income per share for common shares (in dollars, except per share amounts): Three Months Three Months Redeemable Class A Common Stock Numerator: Earnings allocable to Redeemable Class A Common Stock Interest Income $ 31,841 $ 1,452,414 Income Tax and Franchise Tax (31,841 ) (442,446 ) Net Earnings $ — $ 1,009,968 Denominator: Weighted Average Redeemable Class A Common Stock Redeemable Class A Common Stock, Basic and Diluted 35,000,000 35,000,000 Earnings/Basic and Diluted Redeemable Class A Common Stock $ 0.00 $ 0.03 Non-Redeemable Basic Earnings per Share Numerator: Net Income minus Redeemable Net Earnings Net Income $ 28,311,612 $ 5,109,685 Net Earnings allocable to Redeemable Class A Common Stock — (1,009,968 ) Non-Redeemable $ 28,311,612 $ 4,099,717 Denominator: Weighted Average Non-Redeemable Class A and B Non-Redeemable (1) 9,560,000 9,560,000 Income/Basic Non-Redeemable $ 2.96 $ 0.43 Diluted Loss per Share Numerator: Non-Redeemable Net Income – Basic minus Change in fair value of warrant liabilities Non-Redeemable $ 28,311,612 $ 4,099,717 Less: Change in fair value of warrant liabilities (30,171,850 ) (4,294,000 ) Non-Redeemable $ (1,860,238 ) $ (194,283 ) Denominator: Weighted Average Non-Redeemable Class A and B Non-Redeemable (2) 12,757,321 9,560,000 Loss/Diluted Non-Redeemable $ (0.15 ) $ (0.02 ) (1) The weighted average non-redeemable (2) As of March 31, 2021, diluted weighted average shares outstanding was calculated using the treasury stock method utilizing a weighted average share price of $14.00 and the effect of the warrants sold in the Initial Public Offering and the private placement to purchase an aggregate of 17,905,000 shares. As of March 31, 2020, basic and diluted shares are the same as there are no securities that are dilutive to the Company’s common stockholders.	Year Ended For the Redeemable Class A Common Stock Numerator: Earnings allocable to Redeemable Class A Common Stock Interest Income $ 1,671,038 $ 1,809,163 Income Tax and Franchise Tax (612,511 ) (613,244 ) Net Earnings $ 1,058,527 $ 1,195,919 Denominator: Weighted Average Redeemable Class A Common Stock Redeemable Class A Common Stock, Basic and Diluted 35,000,000 35,000,000 Earnings/Basic and Diluted Redeemable Class A Common Stock $ 0.03 $ 0.03 Non-Redeemable Numerator: Net Income minus Redeemable Net Earnings Net (Loss) Income $ (60,723,035 ) $ 2,965,368 Net Earnings applicable to Redeemable Class A Common Stock (1,058,527 ) (1,195,919 ) Non-Redeemable $ (61,781,562 ) $ 1,769,49 Denominator: Weighted Average Non-Redeemable Class A and B Non-Redeemable (1) 9,560,000 9,062,000 Loss/Basic and Diluted Non-Redeemable $ (6.46 ) $ 0.20 Note: As of December 31, 2020 and 2019, basic and diluted shares are the same as there are no securities that are dilutive to the Company’s common stockholders. (1) The weighted average non-redeemable

INCOME TAX (Tables)

INCOME TAX (Tables)	12 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Schedule of deferred tax assets	The Company’s net deferred tax assets are as follows: As of December 31, 2020 2019 Deferred tax asset Organizational costs/Startup expenses $ 1,568,202 $ 61,973 Total deferred tax asset 1,568,202 61,973 Valuation allowance (1,568,202 ) (61,973 ) Deferred tax asset, net of allowance $ — $ —
Schedule of income tax provision	The income tax provision consists of the following: As of December 31, 2020 2019 Federal Current $ 281,381 $ 317,902 Deferred (1,115,020 ) (61,973 ) State Current $ 129,934 $ — Deferred (391,209 ) — Change in valuation allowance 1,506,229 61,973 Income tax provision $ 411,315 $ 317,902
Schedule of reconciliation of the federal income tax	A reconciliation of the federal income tax rate to the Company’s effective tax rate is as follows: As of December 31, 2020 2019 Statutory federal income tax rate 21.0 % 21.0 % State taxes, net of federal tax benefit 7.0 % 0.0 % Change in fair value of warrant liability (26.2 )% 0.0 % Change in valuation allowance (2.5 )% 5.1 % Income tax provision (0.7 )% 26.1 %

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Fair Value Disclosures [Abstract]
Schedule of fair value of held-to-maturity securities		The gross holding losses and fair value of held-to-maturity Held-To-Maturity Amortized Cost Gross Holding Fair Value December 31, 2020 U.S. Treasury Securities $ 176,531,482 $ 2,987 $ 176,534,469 December 31, 2019 U.S. Treasury Securities $ 351,713,981 $ 281,644 $ 351,995,625
Schedule of fair value measured on recurring basis	The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at March 31, 2021 and December 31, 2020 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level March 31, December 31, Assets: Investments – U.S. Treasury Securities Money Market Fund 1 $ 351,889,481 $ 175,325,383 Liabilities: Warrant Liability – Public Warrants 1 45,850,000 74,900,000 Warrant Liability – Private Placement Warrants 3 1,397,250 2,519,100	The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at December 31, 2020 and 2019 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level December 31, December 31, Assets: Investments – U.S. Treasury Securities Money Market Fund 1 $ 175,325,383 $ 94,650 Liabilities: Warrant Liability – Public Warrants 1 74,900,000 20,125,000 Warrant Liability – Private Placement Warrants 3 2,519,100 822,150
Schedule of changes in fair value of Level 3 warrant liabilities		The following table presents the changes in the fair value of Level 3 warrant liabilities: Private Placement Public Warrant Liabilities (Level 3) Fair value as of April 5, 2019 (inception) $ — $ — $ — Initial measurement on September 19, 2019 724,950 23,275,000 23,299,950 Change in valuation inputs or other assumptions 97,200 (175,000 ) (77,800 ) Transfer from Level 3 to Level 2 measurement — (23,100,000 ) (23,100,000 ) Fair value as of December 31, 2019 822,150 — 82,500 Change in valuation inputs or other assumptions (1) 1,696,950 — 1,696,950 Fair value as of December 31, 2020 2,519,000 — 2,519,000 (1) Due to the use of quoted prices in an active market (Level 1) to measure the fair value of the Public Warrants, subsequent to initial measurement, the Company had transfers out of Level 3 totaling $23,100,000 during the period from April 5, 2019 through December 31, 2019.
Schedule of modified black- scholes option pricing model	The key inputs into the Modified Black-Scholes Option Pricing Model for the Warrants were as follows: Input: March 31, December 31, Risk-free interest rate 0.95 % 0.42 % Expected term (years) 5.1 5.4 Expected volatility 34.8 % 34.5 % Exercise price $ 11.50 $ 11.50 Fair value of Units $ 11.08 $ 15.01
Schedule of fair value of warrant liabilities	The following table presents the changes in the fair value of warrant liabilities: Private Placement Public Warrant Liabilities Fair value as of January 1, 2021 $ 2,519,000 $ 74,900,000 $ 77,419,100 Change in valuation inputs or other assumptions (1) (1,121,850 ) (29,050,000 ) (30,171,850 ) Fair value as of March 31, 2021 $ 1,397,250 $ 45,850,000 $ 47,247,250 (1) Changes in valuation inputs or other assumptions are recognized in change in fair value of warrant liabilities in the consolidated statement of operations.

Description of Organization a_2

Description of Organization and Business Operations (Detail) - USD ($)	1 Months Ended	3 Months Ended		9 Months Ended	12 Months Ended
	Sep. 19, 2019	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2019	Dec. 31, 2020
Description of Organization and Business Operations (Textual)
Unit per share (in Dollars per share)		$ 0.20			$ 0.20
Gross proceeds		$ 8,100,000			$ 8,100,000
Offering costs	$ 19,806,442				19,806,442
Underwriting fees	6,100,000				6,100,000
Deferred underwriting fees	13,150,000	$ 13,150,000			13,150,000
Other offering costs	$ 556,442				$ 556,442
Initial public offering amount			$ (5,109,690)	$ 25,000
Business combination, description					The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on interest earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.
Price per share (in Dollars per share)		$ 10			$ 10
Net tangible assets					$ 5,000,001
Public share price (in Dollars per share)		$ 10			$ 10
Percentage of public shares		15.00%			15.00%
Percentage of redeem public shares		100.00%			100.00%
Business combination redemption, description					If the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a "group" (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the "Exchange Act")), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company.
Dissolution expenses		$ 100,000			$ 100,000
Trust account, description		(i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets.			The Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets.
Net tangible assets		$ 5,000,001
Initial Public Offering [Member]
Description of Organization and Business Operations (Textual)
Number of units (in Shares)	35,000,000
Unit per share (in Dollars per share)		$ 10			$ 10
Initial public offering amount	$ 350,000,000
Business combination, description	The Investment Company Act of 1940, as amended (the "Investment Company Act"), with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the Trust Account, as described below.
Price per share (in Dollars per share)	$ 10
Over-Allotment Option [Member]
Description of Organization and Business Operations (Textual)
Number of units (in Shares)	4,500,000
Unit per share (in Dollars per share)	$ 10
Gross proceeds	$ 350,000,000
Private Placement Warrants [Member]
Description of Organization and Business Operations (Textual)
Number of units (in Shares)	810,000	810,000		810,000	810,000
Unit per share (in Dollars per share)	$ 10	$ 10			$ 10
Underwriters [Member]
Description of Organization and Business Operations (Textual)
Gross proceeds	$ 8,100,000				$ 8,100,000

Restatement of Previously Iss_3

Restatement of Previously Issued Financial Statements - Schedule of Financial Statements of Balance Sheet (Detail) - USD ($)	Mar. 31, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Sep. 19, 2019
Balance sheet
Total Liabilities	$ 66,751,378	$ 95,058,844				$ 34,715,394
Additional paid-incapital	34,444,413	62,755,739				2,033,317
(Accumulated deficit) Retained earnings	$ (29,446,055)	(57,757,667)				2,965,368
As Previously Reported [Member]
Balance sheet
Total Liabilities		17,639,744	$ 13,252,231	$ 14,082,333	$ 14,063,126	13,768,244	$ 13,284,099	$ 13,150,815
Class A Common Stock Subject to Possible Redemption		329,968,280	334,703,480	334,879,810	335,035,050	334,219,360	333,347,150	333,314,490
Class A Common Stock		281	234	232	231	239	248	248
Additional paid-incapital		8,349,122	3,613,969	3,437,641	3,282,402	4,098,084	4,970,285	5,002,945
(Accumulated deficit) Retained earnings		(3,350,275)	1,384,926	1,561,255	1,716,495	900,810	28,595	(4,065)
Total Stockholders' Equity		$ 5,000,003	$ 5,000,004	$ 5,000,003	$ 5,000,003	$ 5,000,008	$ 5,000,003	$ 5,000,003
Number of Class A common stock subject to redemption		32,996,828	33,470,348	33,487,981	33,503,505	33,421,936	33,334,715	33,331,449
Adjustments [Member]
Balance sheet
Total Liabilities		$ 77,419,100	$ 35,173,100	$ 30,863,750	$ 16,653,150	$ 20,947,150	$ 23,829,000	$ 23,999,950
Class A Common Stock Subject to Possible Redemption		(77,419,100)	(35,173,100)	(30,863,750)	(16,653,150)	(20,947,150)	(23,829,000)	(23,999,950)
Class A Common Stock		775	352	309	166	209	238	240
Additional paid-incapital		54,406,617	12,161,041	7,851,734	(6,358,723)	(2,064,767)	817,055	988,003
(Accumulated deficit) Retained earnings		$ (54,407,392)	$ (12,161,393)	$ (7,852,043)	$ 6,358,557	$ 2,064,558	$ (817,293)	$ (988,243)
Number of Class A common stock subject to redemption		(7,741,910)	(3,517,310)	(3,086,375)	(1,665,315)	(2,094,715)	(2,382,900)	(2,399,995)
As Restated [Member]
Balance sheet
Total Liabilities		$ 95,058,844	$ 48,425,331	$ 44,946,083	$ 30,716,276	$ 34,715,394	$ 37,113,099	$ 37,150,765
Class A Common Stock Subject to Possible Redemption		252,549,180	299,530,380	304,016,060	318,381,900	313,272,210	309,518,150	309,314,540
Class A Common Stock		1,056	586	541	397	448	486	488
Additional paid-incapital		62,755,739	15,775,010	11,289,375	(3,076,321)	2,033,317	5,787,340	5,990,948
(Accumulated deficit) Retained earnings		(57,757,667)	(10,776,467)	(6,290,788)	8,075,052	2,965,368	(788,698)	(992,308)
Total Stockholders' Equity		$ 5,000,003	$ 5,000,004	$ 5,000,003	$ 5,000,003	$ 5,000,008	$ 5,000,003	$ 5,000,003
Number of Class A common stock subject to redemption		25,254,918	29,953,038	30,401,606	31,838,190	31,327,221	30,951,815	30,931,454

Restatement of Previously Iss_4

Restatement of Previously Issued Financial Statements - Schedule of Financial Statements of Income Statement (Detail) - USD ($)	3 Months Ended					6 Months Ended		9 Months Ended		12 Months Ended
	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Dec. 31, 2019	Dec. 31, 2020
Statement of operations
Weighted average shares outstanding of Class A and Class B non-redeemablecommon stock	35,000,000			35,000,000					35,000,000	35,000,000
Basic and diluted net loss per share, Class A and Class B non-redeemable common stock	$ 0			$ 0.03					$ 0.03	$ 0.03
As Previously Reported [Member]
Statement of operations
Net income (loss)		$ (176,329)	$ (155,240)	$ 815,685	$ 29,595	$ 660,445	$ 28,595	$ 484,116	$ 900,810	$ (4,251,085)
Weighted average shares outstanding of Class A and Class B non-redeemablecommon stock		9,560,000	9,560,000	9,560,000	8,855,652	9,560,000	8,804,607	9,560,000	9,062,000	9,560,000
Basic and diluted net loss per share, Class A and Class B non-redeemable common stock		$ (0.02)	$ (0.02)	$ (0.02)	$ 0	$ (0.04)	$ 0	$ (0.06)	$ (0.03)	$ (0.56)
Adjustments [Member]
Statement of operations
Net income (loss)		$ (14,225,950)	$ (9,916,600)	$ 4,294,000	$ (817,293)	$ (9,916,600)	$ (817,293)	$ (14,225,950)	$ 2,064,558	$ (56,471,950)
Basic and diluted net loss per share, Class A and Class B non-redeemable common stock		$ (1.49)	$ (1.04)	$ 0.45	$ (0.10)	$ (1.04)	$ (0.10)	$ (1.49)	$ 0.23	$ (5.90)
As Restated [Member]
Statement of operations
Net income (loss)		$ (14,402,279)	$ (10,071,840)	$ 5,109,685	$ (787,698)	$ (9,256,155)	$ (788,698)	$ (13,741,834)	$ 2,965,368	$ (60,723,035)
Weighted average shares outstanding of Class A and Class B non-redeemablecommon stock		9,560,000	9,560,000	9,560,000	8,855,652	9,560,000	8,804,607	9,560,000	9,062,000	9,560,000
Basic and diluted net loss per share, Class A and Class B non-redeemable common stock		$ (1.51)	$ (1.06)	$ 0.43	$ (0.10)	$ (1.08)	$ (0.10)	$ (1.55)	$ 0.20	$ (6.46)

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Detail) - USD ($)	3 Months Ended		9 Months Ended	12 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2019	Dec. 31, 2020
Significant Accounting Policies [Line Items]
Maturity period of short term investments, description				The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
Weighted average number of common shares outstanding	35,000,000		35,000,000	35,000,000
Federal depository insurance coverage	$ 250,000		$ 250,000	$ 250,000
Cash	50,000			50,000
Deferred tax assets	2,099,000		$ 61,973	137,000
Full valuation allowance	$ 2,099,000			$ 137,000
Income tax expenses		$ 392,000
Effective tax rate	0.00%	7.00%
Weighted average share price (in Dollars per share)	$ 14
Private Placement Warrants [Member]
Significant Accounting Policies [Line Items]
Proposed public offering number of shares (in Shares)	17,905,000			17,905,000
Initial Public Offering [Member]
Significant Accounting Policies [Line Items]
Offering costs	$ 19,806,442			$ 19,806,442
Offering cost stockholders equity amount	18,818,200			18,818,200
Offering cost expenses	$ 988,242			$ 988,242
Non Redeemable Common Stock [Member]
Significant Accounting Policies [Line Items]
Non redeemable common stock (in Shares)	810,000	810,000	810,000	810,000

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Schedule of basic and diluted net income (loss) per share for common shares (Detail) - USD ($)		3 Months Ended				9 Months Ended		12 Months Ended
		Mar. 31, 2021		Mar. 31, 2020		Dec. 31, 2019		Dec. 31, 2020
Numerator: Earnings allocable to Redeemable Class A Common Stock
Interest Income		$ 31,841		$ 1,452,414		$ 1,809,163		$ 1,671,038
Income Tax and Franchise Tax		$ (31,841)		(442,446)		(613,244)		(612,511)
Net Earnings				$ 1,009,968		$ 1,195,919		$ 1,058,527
Denominator: Weighted Average Redeemable Class A Common Stock
Redeemable Class A Common Stock, Basic and Diluted		35,000,000		35,000,000		35,000,000		35,000,000
Earnings/Basic and Diluted Redeemable Class A Common Stock		$ 0		$ 0.03		$ 0.03		$ 0.03
Numerator: Net Income minus Redeemable Net Earnings
Net (loss) income		$ 28,311,612		$ 5,109,685		$ 2,965,368		$ (60,723,035)
Net Earnings allocable to Redeemable Class A Common Stock				(1,009,968)		(1,195,919)		(1,058,527)
Non-Redeemable Net Income - Basic		$ 28,311,612		$ 4,099,717		$ 176,949		$ (61,781,562)
Class A and B Non-Redeemable Common Stock, Basic	[1]	9,560,000		9,560,000
Income/Basic Non-RedeemableClass A and B Common Stock		$ 2.96		$ 0.43
Class A and B Non-Redeemable Common Stock, Basic and Diluted		12,757,321	[2]	9,560,000	[2]	9,062,000	[3]	9,560,000	[3]
Loss/Basic and Diluted Non-Redeemable Class A and B Common Stock		$ (0.15)		$ (0.02)		$ 0.20		$ (6.46)
Diluted Loss per Share
Non-Redeemable Net Income - Basic		$ 28,311,612		$ 4,099,717
Less: Change in fair value of warrant liabilities		(30,171,850)		(4,294,000)		$ (3,052,800)		$ 56,471,950
Non-Redeemable Net Loss - Diluted		$ (1,860,238)		$ (194,283)
[1]	The weighted average non-redeemable common stock for the three months ended March 31, 2021 and 2020 includes the effect of 810,000 Private Units, which were issued in conjunction with the initial public offering on September 19, 2019.
[2]	As of March 31, 2021, diluted weighted average shares outstanding was calculated using the treasury stock method utilizing a weighted average share price of $14.00 and the effect of the warrants sold in the Initial Public Offering and the private placement to purchase an aggregate of 17,905,000 shares. As of March 31, 2020, basic and diluted shares are the same as there are no securities that are dilutive to the Company's common stockholders.
[3]	The weighted average non-redeemable common stock for the year ended December 31, 2020 and the period from April 6, 2019 (inception) through December 31, 2019, includes the effect of 810,000 Private Units, which were issued in conjunction with the initial public offering on September 19, 2019.

Initial Public Offering (Detail

Initial Public Offering (Detail) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Initial Public Offering (Details) [Line Items]
Sale of units	35,000,000	35,000,000
Sale of stock price per unit	$ 0.20	$ 0.20
Initial Public Offering [Member]
Initial Public Offering (Details) [Line Items]
Option to purchase share price	4,500,000	4,500,000
Sale of stock price per unit	$ 10	$ 10
Class A Common Stock | Initial Public Offering [Member]
Initial Public Offering (Details) [Line Items]
Sale of stock price per unit	$ 11.50	$ 11.50

Private Placement (Detail)

Private Placement (Detail) - USD ($)	1 Months Ended	3 Months Ended	9 Months Ended	12 Months Ended
	Sep. 19, 2019	Mar. 31, 2021	Dec. 31, 2019	Dec. 31, 2020
Private Placement (Details) [Line Items]
Aggregate purchase price (in Dollars)		$ 8,100,000		$ 8,100,000
Price per unit (in Dollars per share)		$ 0.20		$ 0.20
Private Placement Warrants [Member]
Private Placement (Details) [Line Items]
Purchased aggregate units	810,000	810,000	810,000	810,000
Price per unit (in Dollars per share)	$ 10	$ 10		$ 10
Exercisable price per share (in Dollars per share)		$ 11.50		$ 11.50
Sponsor [Member] | Private Placement Warrants [Member]
Private Placement (Details) [Line Items]
Purchased aggregate units		657,500		657,500
Cantor [Member] | Private Placement Warrants [Member]
Private Placement (Details) [Line Items]
Purchased aggregate units		152,500		152,500

Related Party Transactions (Det

Related Party Transactions (Detail) - USD ($)	Sep. 16, 2019	Aug. 13, 2019	Jun. 25, 2019	Sep. 16, 2019	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Feb. 03, 2021
Related Party Transaction [Line Items]
Shares subject to forfeiture of over-allotment option					1,143,750			1,143,750
Percentage of issued and outstanding shares					20.00%			20.00%
Convertible debt					$ 1,500,000			$ 1,500,000
Conversion price					$ 10			$ 10
Administrative expense	$ 15,000				$ 15,000
Fees for services					$ 45,000	$ 45,000	$ 50,500	$ 180,000
Initial Public Offering [Member]
Related Party Transaction [Line Items]
Borrowings outstanding							$ 275,000		$ 275,000
Founder Shares [Member]
Related Party Transaction [Line Items]
Founder Shares no longer subject to forfeiture					1,125,000			1,125,000
Shares issued					8,750,000		8,750,000	8,750,000
Shares outstanding					8,750,000		8,750,000	8,750,000
Common Class B One [Member]
Related Party Transaction [Line Items]
Founder shares							7,187,500		7,187,500
Founder shares, value							$ 25,000		$ 25,000
Common stock dividend payment terms		1.1 for 1		1.109091 for 1
Common stock, shares issued	8,768,750	8,768,750		8,768,750
Common stock, shares outstanding	8,768,750	8,768,750		8,768,750
Description of founder shares					(A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the last sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property.			(A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the last sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property.
Sponsor [Member]
Related Party Transaction [Line Items]
Additional borrowings			$ 300,000
Conversion price										$ 10
Debt Instrument, Annual Principal Payment (in Dollars)										$ 300,000
Outstanding balance amount (in Dollars)					$ 300,000
Over-Allotment Option [Member] | Founder Shares [Member]
Related Party Transaction [Line Items]
Shares subject to forfeiture of over-allotment option					18,750			18,750

Commitments and Contingencies (

Commitments and Contingencies (Detail)	1 Months Ended	3 Months Ended	12 Months Ended
	Nov. 23, 2020	Mar. 31, 2021USD ($)$ / shares	Dec. 31, 2020USD ($)$ / shares	Sep. 19, 2019USD ($)
Commitments and contingencies (Details) [Line Items]
Underwriting agreement description		The Company granted the underwriters a 45-day option to purchase up to 4,575,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. On September 19, 2019, the underwriters partially exercised their over-allotment option to purchase an additional 4,500,000 Units at $10.00 per Unit and forfeited the option to exercise the remaining 75,000 Units.	The Company granted the underwriters a 45-day option to purchase up to 4,575,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. On September 19, 2019, the underwriters partially exercised their over-allotment option to purchase an additional 4,500,000 Units at $10.00 per Unit and forfeited the option to exercise the remaining 75,000 Units.
Underwriting discount		$ 6,100,000	$ 6,100,000
Deferred underwriting fees		$ 13,150,000	$ 13,150,000	$ 13,150,000
Underwriting discount per units (in Dollars per share) | $ / shares		$ 0.20	$ 0.20
Business Combination Agreement [Member]
Commitments and contingencies (Details) [Line Items]
Aggregate cash consideration		$ 35,000,000
Divided exercise price (in Dollars per share) | $ / shares		$ 10	$ 10
Aggregate cash consideration, description		All holders of shares of common stock of AvePoint, par value $0.001 per share ("AvePoint Common Stock") other than the Named Executives will receive an aggregate amount of between $75 million and approximately $93 million in cash (subject to deduction for certain expenses) based on an election ("Cash Election") from the balance of the Aggregate Cash Consideration and will receive the remainder of their consideration in shares of Apex Common Stock from the Aggregate Stock Consideration;	All holders of shares of common stock of AvePoint, par value $0.001 per share ("AvePoint Common Stock") other than the Named Executives will receive an aggregate amount of between $75 million and approximately $92 million in cash (subject to deduction for certain expenses)
Subscription agreements, description	Pursuant to which the PIPE Investors agreed to purchase an aggregate of 14,000,000 shares of Apex Common Stock (the "PIPE Shares"), at a purchase price of $10.00 per share for an aggregate purchase price of $140,000,000, in one or more private placement transactions (the "Private Placements").
Business Combination Agreement [Member] | AvePoint Preferred Stock [Member]
Commitments and contingencies (Details) [Line Items]
Aggregate cash consideration		$ 263,000,000	$ 262,000,000
Aggregate cash consideration, description		(a) 1,000,000 shares of Apex Common Stock, in the aggregate, if at any time from and after the Closing through the seventh anniversary thereof (x) the Closing Price is greater than or equal to $12.50 over any 20 Trading Days within any 30 Trading Day period or (y) Apex consummates a Subsequent Transaction, which results in the stockholders of Apex having the right to exchange their shares for cash, securities or other property having a value equaling or exceeding $12.50 per share (the “First Milestone”) (such 1,000,000 shares of Apex Common Stock, the “First Milestone Contingent Consideration”); (b) 1,000,000 shares of Apex Common Stock, in the aggregate, if at any time from and after the Closing through the seventh anniversary thereof (x) the Closing Price is greater than or equal to $15.00 over any 20 Trading Days within any 30 Trading Day period or (y) Apex consummates a Subsequent Transaction, which results in the stockholders of Apex having the right to exchange their shares for cash, securities or other property having a value equaling or exceeding $15.00 per share (the “Second Milestone”) (such 1,000,000 shares of Apex Common Stock, the “Second Milestone Contingent Consideration”); and (c) 1,000,000 shares of Apex Common Stock, in the aggregate, if at any time from and after the Closing through the seventh anniversary thereof (x) the Closing Price is greater than or equal to $17.50 over any 20 Trading Days within any 30 Trading Day period or (y) Apex consummates a Subsequent Transaction, which results in the stockholders of Apex having the right to exchange their shares for cash, securities or other property having a value equaling or exceeding $17.50 per share (the “Third Milestone”) (such 1,000,000 shares of Apex Common Stock, the “Third Milestone Contingent Consideration” and together with the First Milestone Contingent Consideration and the Second Milestone Contingent Consideration, the “Contingent Consideration”). For the avoidance of doubt, the maximum amount of the Contingent Consideration is 3,000,000 shares of Apex Common Stock, in the aggregate.	(a) 1,000,000 shares of Apex Common Stock, in the aggregate, if at any time from and after the Closing through the seventh anniversary thereof (x) the Closing Price is greater than or equal to $12.50 over any 20 Trading Days within any 30 Trading Day period or (y) Apex consummates a Subsequent Transaction, which results in the stockholders of Apex having the right to exchange their shares for cash, securities or other property having a value equaling or exceeding $12.50 per share (the “First Milestone”) (such 1,000,000 shares of Apex Common Stock, the “First Milestone Contingent Consideration”); (b) 1,000,000 shares of Apex Common Stock, in the aggregate, if at any time from and after the Closing through the seventh anniversary thereof (x) the Closing Price is greater than or equal to $15.00 over any 20 Trading Days within any 30 Trading Day period or (y) Apex consummates a Subsequent Transaction, which results in the stockholders of Apex having the right to exchange their shares for cash, securities or other property having a value equaling or exceeding $15.00 per share (the “Second Milestone”) (such 1,000,000 shares of Apex Common Stock, the “Second Milestone Contingent Consideration”); and (c) 1,000,000 shares of Apex Common Stock, in the aggregate, if at any time from and after the Closing through the seventh anniversary thereof (x) the Closing Price is greater than or equal to $17.50 over any 20 Trading Days within any 30 Trading Day period or (y) Apex consummates a Subsequent Transaction, which results in the stockholders of Apex having the right to exchange their shares for cash, securities or other property having a value equaling or exceeding $17.50 per share (the “Third Milestone”) (such 1,000,000 shares of Apex Common Stock, the “Third Milestone Contingent Consideration” and together with the First Milestone Contingent Consideration and the Second Milestone Contingent Consideration, the “Contingent Consideration”). For the avoidance of doubt, the maximum amount of the Contingent Consideration is 3,000,000 shares of Apex Common Stock, in the aggregate.
Business Combination Agreement [Member] | AvePoint Preferred Stock [Member] | Series C Preferred Stock [Member]
Commitments and contingencies (Details) [Line Items]
Aggregate cash consideration		$ 135,000,000	$ 135,000,000
Common stock, par value | $ / shares		$ 0.001	$ 0.001
Business Combination Agreement [Member] | Apex Common Stock [Member]
Commitments and contingencies (Details) [Line Items]
Aggregate cash consideration			$ 35,000,000
Share of common stock (in Shares)		143,210,835	143,261,093
Common stock, par value | $ / shares			$ 0.0001

Stockholders' Equity (Detail)

Stockholders' Equity (Detail) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Stockholders' Equity Detail [Line Items]
Preferred stock shares authorized	1,000,000	1,000,000	1,000,000
Preferred stock par value (in Dollars per share)	$ 0.0001	$ 0.0001	$ 0.0001
Percentage of conversion of shares	20.00%	20.00%
Class A Common Stock
Stockholders' Equity Detail [Line Items]
Common stock authorized shares	100,000,000	100,000,000	100,000,000
Common stock par value (in Dollars per share)	$ 0.0001	$ 0.0001	$ 0.0001
Common stock shares issued	7,723,921	10,555,082	4,482,779
Common stock shares outstanding	7,723,921	10,555,082	4,482,779
Shares subject to possible redemption		25,254,918	31,327,221
Common stock subject to possible redemption	$ 28,086,079	$ 25,254,918
Class B Common Stock
Stockholders' Equity Detail [Line Items]
Common stock authorized shares	10,000,000	10,000,000	10,000,000
Common stock par value (in Dollars per share)	$ 0.0001	$ 0.0001	$ 0.0001
Common stock shares issued	8,750,000	8,750,000	8,750,000
Common stock shares outstanding	8,750,000	8,750,000	8,750,000

Warrant Liabilities (Detail)

Warrant Liabilities (Detail)	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Warrants exercisable, description	the warrants become exercisable, the Company may redeem the Public Warrants: o in whole and not in part; o at a price of $0.01 per warrant; o upon not less than 30 days' prior written notice of redemption given after the warrants become exercisable; and o if, and only if, the reported last sale price of the Company's Class A common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period commencing once the warrants become exercisable and ending three business days before the Company sends the notice of redemption to the warrant holders.	the warrants become exercisable, the Company may redeem the Public Warrants: o in whole and not in part; o at a price of $0.01 per warrant; o upon not less than 30 days' prior written notice of redemption given after the warrants become exercisable; and o if, and only if, the reported last sale price of the Company's Class A common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period commencing once the warrants become exercisable and ending three business days before the Company sends the notice of redemption to the warrant holders.
Class A Common Stock
Warrants exercisable, description	the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the shares of Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates a Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.	the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the shares of Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates a Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.

Income Tax - Schedule of deferr

Income Tax - Schedule of deferred tax assets (Detail) - USD ($)	Mar. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Deferred tax asset
Organizational costs/Startup expenses		$ 1,568,202	$ 61,973
Total deferred tax asset	$ 2,099,000	137,000	61,973
Valuation allowance		(1,568,202)	(61,973)
Deferred tax asset, net of allowance		0	$ 0
As Previously Reported [Member]
Deferred tax asset
Total deferred tax asset		$ 1,568,202

Income Tax - Schedule of income

Income Tax - Schedule of income tax provision (Detail) - USD ($)	3 Months Ended	9 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Federal
Current			$ 281,381	$ 317,902
Deferred			(1,115,020)	(61,973)
State
Current			129,934
Deferred			(391,209)
Change in valuation allowance		$ 61,973	1,506,229	61,973
Income tax provision	$ 392,446	$ 317,902	$ 411,315	$ 317,902

Income Tax (Detail)

Income Tax (Detail) - USD ($)	9 Months Ended	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Income Tax (Textual)
Change in the valuation allowance	$ 61,973	$ 1,506,229	$ 61,973

Income Tax - Schedule of reconc

Income Tax - Schedule of reconciliation of the federal income tax (Detail)	9 Months Ended	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Statutory federal income tax rate	21.00%	21.00%
State taxes, net of federal tax benefit	0.00%	7.00%
Change in fair value of warrant liability	0.00%	(26.20%)
Change in valuation allowance	5.10%	(2.50%)
Income tax provision	26.10%	(0.70%)

Fair Value Measurements (Detail

Fair Value Measurements (Detail) - USD ($)	3 Months Ended	9 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Mar. 31, 2021
Cash			$ 50,000	$ 50,000
Trust account		$ 532	1,455	680
Invested in U.S. Treasury Securities		351,713,981	176,531,482
Interest expense	$ 148,743		1,621,881
US Treasury Securities [Member]
Cash			$ 175,325,383	$ 351,889,481
Money Market Funds [Member]
Trust account		94,650
Warrants Liabilities [Member] | Level 3 [Member]
Transfer from Level 3 to Level 2 measurement		$ 23,100,000

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of fair value of held-to-maturity securities (Detail) - US Treasury Securities [Member] - USD ($)	9 Months Ended	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2020
Held-To-Maturity	Mar. 19, 2020	Jan. 19, 2021
Amortized Cost	$ 351,713,981	$ 176,531,482
Gross Holding (Loss) Gains	281,644	2,987
Fair Value	$ 351,995,625	$ 176,534,469

Fair Value Measurements - Sch_2

Fair Value Measurements - Schedule of fair value measured on recurring basis (Detail) - USD ($)	Mar. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Assets:
Investments - U.S. Treasury Securities Money Market Fund	$ 351,889,481	$ 175,325,383	$ 94,650
Liabilities:
Warrant Liability - Public Warrants	45,850,000	74,900,000	20,125,000
Warrant Liability - Private Placement Warrants	$ 1,397,250	$ 2,519,100	$ 822,150

Fair Value Measurements - Sch_3

Fair Value Measurements - Schedule of fair value of warrant liabilities (Detail) - USD ($)		3 Months Ended		9 Months Ended	12 Months Ended
		Mar. 31, 2021		Dec. 31, 2019	Dec. 31, 2020
Private Placement Warrants [Member]
Fair value beginning balance		$ 2,519,000			$ 822,150
Initial measurement on September 19, 2019				$ 724,950
Change in valuation inputs or other assumptions		(1,121,850)	[1]	97,200	1,696,950	[2]
Fair value ending balance		1,397,250		822,150	2,519,000
Public [Member]
Fair value beginning balance		74,900,000
Initial measurement on September 19, 2019				23,275,000
Change in valuation inputs or other assumptions		(29,050,000)	[1]	(175,000)
Transfer from Level 3 to Level 2 measurement				(23,100,000)
Fair value ending balance		45,850,000			74,900,000
Warrants Liabilities [Member]
Fair value beginning balance		77,419,100
Change in valuation inputs or other assumptions	[1]	(30,171,850)
Fair value ending balance		47,247,250			77,419,100
Warrants Liabilities [Member] | Level 3 [Member]
Fair value beginning balance		$ 2,519,000			82,500
Initial measurement on September 19, 2019				23,299,950
Change in valuation inputs or other assumptions				(77,800)	1,696,950	[2]
Transfer from Level 3 to Level 2 measurement				(23,100,000)
Fair value ending balance				$ 82,500	$ 2,519,000
[1]	Changes in valuation inputs or other assumptions are recognized in change in fair value of warrant liabilities in the consolidated statement of operations.
[2]	Due to the use of quoted prices in an active market (Level 1) to measure the fair value of the Public Warrants, subsequent to initial measurement, the Company had transfers out of Level 3 totaling $23,100,000 during the period from April 5, 2019 through December 31, 2019.

Fair Value Measurements - Sch_4

Fair Value Measurements - Schedule of modified black- scholes option pricing model (Detail) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Schedule of modified black- scholes option pricing mode [Abstract]
Risk-free interest rate	0.95%	0.42%
Expected term (years)	5 years 36 days	5 years 146 days
Expected volatility	34.80%	34.50%
Exercise price	$ 11.50	$ 11.50
Fair value of Units	$ 11.08	$ 15.01